source,citation,relation,ID,title,authors,journal,year,fulltext_online_link,fulltext_location
10.1002~hep.510260130," served in a subset of HCV-infected liver transplant recipients,",references,NOT found in MAS
10.1002~hep.510260130,"Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer Jr HC, Perrillo in whom the viral RNA became undetectable by reverseRP, Carey W, et al. Treatment of chronic hepatitis C with recombinant transcriptase PCR within 3 days after liver transplantation.19 interferon alfa: a multicenter, randomized, controlled study. N Engl J We have not tried to estimate the half-life of infected cells, Med 1989;321:1501-1506. because we only have data for the first 2 days following a 2. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, et al. Recombinant interferon alfa therapy single dose of IFN-a. for chronic hepatitis C: a randomized double-blind placebo-controlled The responsiveness of genotype 1 HCV to a single high trial. N Engl J Med 1989;321:1506-1510. dose of IFN-a, as shown in our study, suggests that resistance 3. Shindo M, Di Bisceglie AM, Cheung L, Shih JWL, Cristiano K, Feinstone to IFN-a therapy in patients infected with genotype 1 HCV SM, Hoofnagle JH. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991; may be caused by inadequate dosing and not to complete 115:700-704. viral resistance of genotype 1 to the drug. Genotype 1 HCV",references,NOT found in MAS
10.1002~hep.510260130,"Lau JYN, Mizokami M, Ohno T, Diamond DA, Kniffen J, Davis GL. may be less sensitive to IFN-a than other genotypes, and thus Discrepancy between biochemical and virological responses to interthe same dose of IFN-a gives a lower therapeutic efficacy. feron-alpha in chronic hepatitis C. Lancet 1993;341:1208-1209. Alternatively, genotype 1 HCV may have a larger production 5. Lau JYN, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, et al. Significance of serum hepatitis C virus RNA levels in chronic rate than other genotypes, and thus the same treatment effihepatitis. Lancet 1993;341:1501-1504. cacy may give rise to a slower decay of HCV. More data are",references,NOT found in MAS
10.1002~hep.510260130,"Hagiwara H, Hayashi N, Mita E, Takehara J, Kasahara A, Hideyuki F, needed to distinguish between these hypotheses. Kamada T. Quantitative analysis of hepatitis C virus RNA in serum Another observation of the current study is the transient during interferon alfa therapy. Gastroenterology 1993;104:877-893.",references,NOT found in MAS
10.1002~hep.510260130,"Shindo M, DiBisceglie AM, Hoofnagle JH. Long term follow up of panature of the antiviral effect seen with a single dose of IFNtients with chronic hepatitis C treated with alpha-interferon. HEPATOLa, particularly with a 3-mIU dose of IFN-a. Although not OGY 1992;15:1013-1016. significant, the HCV-RNA levels also rose between 24 and",references,NOT found in MAS
10.1002~hep.510260130,"Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of 48 hours after a 5- or 10-mIU dose of IFN-a in some patients. variability in the amino terminal regions of the E2/NS1 protein of hepatiWe do not know how long it takes the HCV-RNA levels to tis C virus correlates with responsiveness to interferon therapy in viremic patients. HEPATOLOGY 1992;16:619-624. return to the pretreatment levels after a single dose of IFN-",references,NOT found in MAS
10.1002~hep.510260130,"Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto a; however, our data with a 3-mIU dose of IFN-a suggest M, et al. Factors predictive of response to interferon-a therapy in hepatithat the maximum effect of IFN-a wanes after 24 hours in tis C virus infection. HEPATOLOGY 1994;19:1088-1094. patients with HCV genotype 1. This challenges the dogma 10. Yoshioka K, Kakumu S, Wakita T, Ishikama T, Itoh Y, Takayanagi M, Higashi Y, et al. Detection of hepatitis C virus by polymerase chain that the current recommended IFN-a dosing schedule, i.e., AID Hepa 0031 / 5p22$$$601 06-11-97 14:14:55 hepa WBS: Hepatology HEPATOLOGY Vol. 26, No. 1, 1997 LAM ET AL. 231 reaction and response to interferon-a therapy: relationship to genotypes Boyer N, Lemonnier C, et al. Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C. Gastroenterology of hepatitis C virus. HEPATOLOGY 1992;16:293-299. 1995;109:156-165.",references,NOT found in MAS
10.1002~hep.510260130,"Mahaney K, Tedeschi V, Maertens G, Di Bisceglie AM, Vergalla J, Hoof-",references,NOT found in MAS
10.1002~hep.510260130,"Iino S. High dose interferon treatment in chronic hepatitis C. Gut 1993; nagle JH, Salli R. Genotypic analysis of hepatitis C virus in American (Suppl):S114-S118. patients. HEPATOLOGY 1994;20:1405-1411.",references,NOT found in MAS
10.1002~hep.510260130,"Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N,",references,NOT found in MAS
10.1002~hep.510260130,"Knodell RG, Ishak KG, Black WC, Chen TS, Criag R, Kaplowitz N, Poliquin M, Degott C, et al. Pretreatment serum hepatitis C virus RNA Kiernan TW, et al. Formulation and application of a numerical scoring levels and hepatitis C virus genotype are the main and independent system for assessing histological activity in asymptomatic chronic active prognostic factors of sustained response to interferon alfa therapy in hepatitis. HEPATOLOGY 1981;1:431-435. chronic hepatitis C. HEPATOLOGY 1995;22:1050-1056.",references,NOT found in MAS
10.1002~hep.510260130,"Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz",references,NOT found in MAS
10.1002~hep.510260130,"Chemello L, Bonetti P, Cavalletto L, Talato F, Donadon V, Casarin P, M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 Belussi F, et al. Randomized trial comparing three different regimens infection. Nature 1995;373:123-126. of alpha-2a-interferon in chronic hepatitis C. HEPATOLOGY 1995;22:",references,NOT found in MAS
10.1002~hep.510260130,"Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka 700-706. T, et al. Typing hepatitis C virus by polymerase chain reaction with type-",references,NOT found in MAS
10.1002~hep.510260130,"Okamoto H, Kojima M, Okada SI, Yoshizawa H, Iizuka H, Tanaka T, specific primers: application to clinical surveys and tracing infections Muchmore EE, et al. Genetic drift of hepatitis C virus during an 8.2-sources. J Gen Virol 1992;73:673-679. year infection in a chimpanzee: variability and stability. Virology 1992;",references,NOT found in MAS
10.1002~hep.510260130,"Gretch D, Lee W, Corey L. Use of aminotransferase, hepatitis C anti190:894-899. body, and hepatitis C polymerase chain reaction RNA assays to establish",references,NOT found in MAS
10.1002~hep.510260130,"Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and the diagnosis of hepatitis C virus infection in a diagnostic virology mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci laboratory. J Clin Microbiol 1992;30:2145-2149. U S A 1991;88:3392-3396.",references,10.1073/pnas.88.8.3392,Nucleotide Sequence and Mutation Rate of the H Strain of Hepatitis C Virus,"[[u'N.', u'', u'Ogata'], [u'Hj', u'', u'Alter'], [u'Rh', u'', u'Miller'], [u'Rh', u'', u'Purcell']]",Proceedings of The National Academy of Sciences,1991,[u'http://www.pnas.org/cgi/doi/10.1073/pnas.88.8.3392'],./output/10.1002~hep.510260130/10.1073~pnas.88.8.3392
10.1073/pnas.88.8.3392,"Okamoto, H., Sugiyama, Y., Okada, S., et. al, Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources, Journal of General Virology, 1992",cited-by,10.1099/0022-1317-73-3-673,Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources,"[['Hiroaki', '', 'Okamoto'], ['Yasushi', '', 'Sugiyama'], ['Shunichi', '', 'Okada'], ['Kiyohiko', '', 'Kurai'], ['Yoshihiro', '', 'Akahane'], ['Yoshiki', '', 'Sugai'], ['Takeshi', '', 'Tanaka'], ['Koei', '', 'Sato'], ['Fumio', '', 'Tsuda'], ['Yuzo', '', 'Miyakawa'], ['M.', '', 'Mayumi']]",Journal of General Virology,1992,"[u'http://intl-vir.sgmjournals.org/cgi/reprint/73/3/673.pdf', u'http://jgv.sgmjournals.org/cgi/reprint/73/3/673.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-73-3-673']"
10.1073/pnas.88.8.3392,"Simmonds, P., Holmes, E., Cha, T., et. al, Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region, Journal of General Virology, 1993",cited-by,10.1099/0022-1317-74-11-2391,Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region,"[['P.', '', 'Simmonds'], ['E.', 'C.', 'Holmes'], ['T.-A.', '', 'Cha'], ['S.-W.', '', 'Chan'], ['F.', '', 'McOmish'], ['B.', '', 'Irvine'], ['E.', '', 'Beall'], ['P.', 'L.', 'Yap'], ['J.', '', 'Kolberg'], ['M.', 'S.', 'Urdea']]",Journal of General Virology,1993,"[u'http://jgv.sgmjournals.org/cgi/reprint/74/11/2391.pdf', u'http://vir.sgmjournals.org/cgi/reprint/74/11/2391.pdf', u'http://intl-vir.sgmjournals.org/cgi/reprint/74/11/2391.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-74-11-2391']"
10.1073/pnas.88.8.3392,"Penin, F., Rice, C., Moradpour, D., , Replication of hepatitis C virus, Nature Reviews Microbiology, 2007",cited-by,10.1038/nrmicro1645,Replication of hepatitis C virus,"[['Fran\xc3\xa7ois', '', 'Penin'], ['Charles', 'M.', 'Rice'], ['Darius', '', 'Moradpour']]",Nature Reviews Microbiology,2007,"[u'http://www.hawaii.edu/hivandaids/Replication%20of%20Hepatits%20C%20Virus.pdf', u'http://vir.sgmjournals.org/cgi/reprint/81/7/1631.pdf', u'http://jgv.sgmjournals.org/cgi/reprint/81/7/1631.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/hcv/replicationofhcv.pdf', u'http://hepatitis-central.com/hcv/info/2004/hcv/replicationofhcv.pdf', u'http://www.nature.com/doifinder/10.1038/nrmicro1645', u'http://dx.doi.org/10.1038/nrmicro1645']"
10.1073/pnas.88.8.3392,"Chan, S., McOmish, F., Holmes, E., et. al, Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants, Journal of General Virology, 1992",cited-by,10.1099/0022-1317-73-5-1131,Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants,"[['S.-W.', '', 'Chan'], ['F.', '', 'McOmish'], ['E.', 'C.', 'Holmes'], ['B.', '', 'Dow'], ['J.', 'F.', 'Peutherer'], ['E.', '', 'Follett'], ['P.', 'L.', 'Yap'], ['P.', '', 'Simmonds']]",Journal of General Virology,1992,"[u'http://vir.sgmjournals.org/cgi/reprint/73/5/1131.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-73-5-1131']"
10.1073/pnas.88.8.3392,"BIGGER, C., BRASKY, K., LANFORD, R., , DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection, Journal of Virology, 2001",cited-by,10.1128/JVI.75.15.7059-7066.2001,DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection,"[['CATHERINE', 'B.', 'BIGGER'], ['KATHLEEN', 'M.', 'BRASKY'], ['ROBERT', 'E.', 'LANFORD']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/15/7059.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.15.7059-7066.2001']"
10.1073/pnas.88.8.3392,"Okada, S., Akahane, Y., Suzuki, H., et. al, The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients, Hepatology, 1992",cited-by,10.1002/hep.1840160302,The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients,"[['Shun-Ichi', '', 'Okada'], ['Yoshihirc', '', 'Akahane'], ['Hiroshi', '', 'Suzuki'], ['Hiroaki', '', 'Okamoto'], ['Shunji', '', 'Mishiro']]",Hepatology,1992,[u'http://doi.wiley.com/10.1002/hep.1840160302']
10.1073/pnas.88.8.3392,"ZEIN, N., , Clinical Significance of Hepatitis C Virus Genotypes, Clinical Microbiology Reviews, 2000",cited-by,10.1128/CMR.13.2.223-235.2000,Clinical Significance of Hepatitis C Virus Genotypes,"[['NIZAR', 'N.', 'ZEIN']]",Clinical Microbiology Reviews,2000,"[u'http://cmr.asm.org/cgi/reprint/13/2/223.pdf', u'http://cmr.asm.org/cgi/doi/10.1128/CMR.13.2.223-235.2000']"
10.1073/pnas.88.8.3392,"Simmonds, P., , Viral heterogeneity of the hepatitis C virus, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80375-4,Viral heterogeneity of the hepatitis C virus,"[['Peter', '', 'Simmonds']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803754', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803754']"
10.1073/pnas.88.8.3392,"Mellor, J., Holmes, E., Jarvis, L., et. al, Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification, Journal of General Virology, 1995",cited-by,10.1099/0022-1317-76-10-2493,Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification,"[['J.', '', 'Mellor'], ['E.', 'C.', 'Holmes'], ['L.', 'M.', 'Jarvis'], ['P.', 'L.', 'Yap']]",Journal of General Virology,1995,[u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-76-10-2493']
10.1073/pnas.88.8.3392,"DETMER, J., LAGIER, R., FLYNN, J., et. al, Accurate Quantification of Hepatitis C Virus (HCV) RNA from All HCV Genotypes by Using Branched-DNA Technology, , 1996",cited-by,5976810Accurate Quantification of Hepatitis C Virus (HCV) RNA from All HCV Genotypes by Using Branched-DNA Technology,Accurate Quantification of Hepatitis C Virus (HCV) RNA from All HCV Genotypes by Using Branched-DNA Technology,"[['JILL', '', 'DETMER'], ['ROBERT', '', 'LAGIER'], ['JULIE', '', 'FLYNN'], ['CRYSTLE', '', 'ZAYATI'], ['JANICE', '', 'KOLBERG'], ['MARK', '', 'COLLINS'], ['MICKEY', '', 'URDEA'], ['ANDRAY', '', 'SANCHEZ-PESCADOR']]",,1996,[u'http://jcm.asm.org/cgi/reprint/34/4/901.pdf']
10.1073/pnas.88.8.3392,"Enomoto, N., Kurosaki, M., Tanaka, Y., et. al, Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis, Journal of General Virology, 1994",cited-by,10.1099/0022-1317-75-6-1361,Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis,"[['Nobuyuki', '', 'Enomoto'], ['Masayuki', '', 'Kurosaki'], ['Yujiro', '', 'Tanaka'], ['Fumiaki', '', 'Marumo'], ['C.', '', 'Sato']]",Journal of General Virology,1994,"[u'http://vir.sgmjournals.org/cgi/reprint/75/6/1361.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-75-6-1361']"
10.1073/pnas.88.8.3392,"CHAYAMA, K., TSUBOTA, A., ARASE, Y., et. al, Genotypic subtyping of hepatitis C virus, Journal of Gastroenterology and Hepatology, 1993",cited-by,10.1111/j.1440-1746.1993.tb01507.x,Genotypic subtyping of hepatitis C virus,"[['KAZUAKI', '', 'CHAYAMA'], ['AKIHITO', '', 'TSUBOTA'], ['YASUJI', '', 'ARASE'], ['SATOSHI', '', 'SAITOH'], ['ISAO', '', 'KOIDA'], ['KENJI', '', 'IKEDA'], ['TOYOMI', '', 'MATSUMOTO'], ['MARIKO', '', 'KOBAYASHI'], ['SATOMI', '', 'IWASAKI'], ['SHIMA', '', 'KOYAMA'], ['TSUTO', '', 'MORINAGA'], ['HIROMITSU', '', 'KUMADA']]",Journal of Gastroenterology and Hepatology,1993,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.1993.tb01507.x']
10.1073/pnas.88.8.3392,"Wieland, S., Chisari, F., , Stealth and Cunning: Hepatitis B and Hepatitis C Viruses, Journal of Virology, 2005",cited-by,10.1128/JVI.79.15.9369-9380.2005,Stealth and Cunning: Hepatitis B and Hepatitis C Viruses,"[['Stefan', 'F.', 'Wieland'], ['Francis', 'V.', 'Chisari']]",Journal of Virology,2005,"[u'http://jvi.highwire.org/cgi/reprint/79/15/9369.pdf', u'http://jvi.asm.org/cgi/reprint/79/15/9369.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.15.9369-9380.2005']"
10.1073/pnas.88.8.3392,"Mita, E., Hayashi, N., Hagiwara, H., et. al, Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer, Digestive Diseases and Sciences, 1994",cited-by,10.1007/BF02087547,Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer,"[['Eiji', '', 'Mita'], ['Norio', '', 'Hayashi'], ['Hideki', '', 'Hagiwara'], ['Keiji', '', 'Ueda'], ['Yoshiyuki', '', 'Kanazawa'], ['Akinori', '', 'Kasahara'], ['Hideyuki', '', 'Fusamoto'], ['Takenobu', '', 'Kamada']]",Digestive Diseases and Sciences,1994,"[u'http://www.springerlink.com/content/xv63kp7960100v82', u'http://www.springerlink.com/index/xv63kp7960100v82.pdf', u'http://www.springerlink.com/index/10.1007/BF02087547', u'http://www.springerlink.com/index/pdf/10.1007/BF02087547']"
10.1073/pnas.88.8.3392,"Clarke, B., , Molecular virology of hepatitis C virus, , 1997",cited-by,3410695Molecular virology of hepatitis C virus,Molecular virology of hepatitis C virus,"[['B.', '', 'Clarke']]",,1997,[]
10.1073/pnas.88.8.3392,"Pozzato, G., Kaneko, S., Moretti, M., et. al, Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease, Journal of Medical Virology, 1994",cited-by,10.1002/jmv.1890430318,Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease,"[['Gabriele', '', 'Pozzato'], ['Suichi', '', 'Kaneko'], ['Mich\xc3\xa9le', '', 'Moretti'], ['Lory', 'Saveria', 'Croce'], ['Francesco', '', 'Franzin'], ['Masashi', '', 'Unoura'], ['Luisa', '', 'Bercich'], ['Claudio', '', 'Tiribelli'], ['Marina', '', 'Crovatto'], ['Gianfranco', '', 'Santini'], ['Kenichi', '', 'Kobayashi']]",Journal of Medical Virology,1994,[u'http://doi.wiley.com/10.1002/jmv.1890430318']
10.1073/pnas.88.8.3392,"Smith, D., Pathirana, S., Davidson, F., et. al, The origin of hepatitis C virus genotypes, , 1997",cited-by,6952171The origin of hepatitis C virus genotypes,The origin of hepatitis C virus genotypes,"[['Donald', 'B.', 'Smith'], ['Steve', '', 'Pathirana'], ['Fiona', '', 'Davidson'], ['Emer', '', 'Lawlor'], ['Joan', '', 'Power'], ['Peng', 'Lee', 'Yap']]",,1997,[u'http://vir.sgmjournals.org/cgi/reprint/78/2/321.pdf']
10.1073/pnas.88.8.3392,"Kronke, J., Kittler, R., Buchholz, F., et. al, Alternative Approaches for Efficient Inhibition of Hepatitis C Virus RNA Replication by Small Interfering RNAs, Journal of Virology, 2004",cited-by,10.1128/JVI.78.7.3436-3446.2004,Alternative Approaches for Efficient Inhibition of Hepatitis C Virus RNA Replication by Small Interfering RNAs,"[['Jan', '', 'Kronke'], ['Ralf', '', 'Kittler'], ['Frank', '', 'Buchholz'], ['Marc', 'P.', 'Windisch'], ['Thomas', '', 'Pietschmann'], ['Ralf', '', 'Bartenschlager'], ['Michael', '', 'Frese']]",Journal of Virology,2004,"[u'http://www.mpi-cbg.de/nc/en/research/research-groups/frank-buchholz/publications.html?tx_awpublications_pi1[download]=310', u'http://jvi.asm.org/cgi/reprint/78/7/3436.pdf', u'http://www.mpi-cbg.de/nc/research/research-groups/frank-buchholz/publications.html?tx_awpublications_pi1[download]=310', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.7.3436-3446.2004']"
10.1073/pnas.88.8.3392,"Contreras, A., Hiasa, Y., He, W., et. al, Viral RNA Mutations Are Region Specific and Increased by Ribavirin in a Full-Length Hepatitis C Virus Replication System, Journal of Virology, 2002",cited-by,10.1128/JVI.76.17.8505-8517.2002,Viral RNA Mutations Are Region Specific and Increased by Ribavirin in a Full-Length Hepatitis C Virus Replication System,"[['Ana', 'Maria', 'Contreras'], ['Yoichi', '', 'Hiasa'], ['Wenping', '', 'He'], ['Adam', '', 'Terella'], ['Emmett', 'V.', 'Schmidt'], ['Raymond', 'T.', 'Chung']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/17/8505.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.17.8505-8517.2002']"
10.1073/pnas.88.8.3392,"RAY, S., WANG, Y., LAEYENDECKER, O., et. al, Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy, , 1999",cited-by,13412001Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy,Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy,"[['STUART', 'C.', 'RAY'], ['YU-MING', '', 'WANG'], ['OLIVER', '', 'LAEYENDECKER'], ['JOHN', 'R.', 'TICEHURST'], ['STEPHEN', 'A.', 'VILLANO'], ['DAVID', 'L.', 'THOMAS']]",,1999,[u'http://jvi.asm.org/cgi/reprint/73/4/2938.pdf']
10.1073/pnas.88.8.3392,"Hahn, T., Yoon, J., Alter, H., et. al, Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo, Gastroenterology, 2007",cited-by,10.1053/j.gastro.2006.12.008,Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo,"[['Thomas', 'von', 'Hahn'], ['Joo', 'Chun', 'Yoon'], ['Harvey', '', 'Alter'], ['Charles', 'M.', 'Rice'], ['Barbara', '', 'Rehermann'], ['Peter', '', 'Balfe'], ['Jane', 'A.', 'McKeating']]",Gastroenterology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506025662', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506025662']"
10.1073/pnas.88.8.3392,"Koziel, M., , The role of immune responses in the pathogenesis of hepatitis C virus infection, Journal of Viral Hepatitis, 1997",cited-by,10.1111/j.1365-2893.1997.tb00178.x,The role of immune responses in the pathogenesis of hepatitis C virus infection,"[['M.', 'J.', 'Koziel']]",Journal of Viral Hepatitis,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.1997.tb00178.x']
10.1073/pnas.88.8.3392,"Owsianka, A., Clayton, R., Loomis-Price, L., et. al, Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2, , 2001",cited-by,7026538Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2,Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2,"[['Ania', '', 'Owsianka'], ['Reginald', 'F.', 'Clayton'], ['Lawrence', 'D.', 'Loomis-Price'], ['Jane', 'A.', 'McKeating']]",,2001,[u'http://vir.sgmjournals.org/cgi/reprint/82/8/1877.pdf']
10.1073/pnas.88.8.3392,"Okamoto, H., Tsuda, F., Machida, A., et. al, Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis C virus infection, Hepatology, 1992",cited-by,10.1002/hep.1840150203,Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis C virus infection,"[['Hiroaki', '', 'Okamoto'], ['Fumio', '', 'Tsuda'], ['Atsuhiko', '', 'Machida'], ['Eisuke', '', 'Munekata'], ['Yoshihiro', '', 'Akahane'], ['Yoshiki', '', 'Sugai'], ['Kazuo', '', 'Mashiko'], ['Takehiro', '', 'Mitsui'], ['Takeshi', '', 'Tanaka'], ['Yuzo', '', 'Miyakawa'], ['Makoto', '', 'Mayumi']]",Hepatology,1992,[u'http://doi.wiley.com/10.1002/hep.1840150203']
10.1073/pnas.88.8.3392,"MAJOR, M., MIHALIK, K., FERNANDEZ, J., et. al, Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus, , 1999",cited-by,13885038Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus,Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus,"[['MARIAN', 'E.', 'MAJOR'], ['KATHLEEN', '', 'MIHALIK'], ['JAVIER', '', 'FERNANDEZ'], ['JESSICA', '', 'SEIDMAN'], ['DAVID', '', 'KLEINER'], ['ALEXANDER', 'A.', 'KOLYKHALOV'], ['CHARLES', 'M.', 'RICE'], ['STEPHEN', 'M.', 'FEINSTONE']]",,1999,[u'http://jvi.asm.org/cgi/reprint/73/4/3317.pdf']
10.1073/pnas.88.8.3392,"MCALLISTER, J., CASINO, C., DAVIDSON, F., et. al, Long-Term Evolution of the Hypervariable Region of Hepatitis C Virus in a Common-Source-Infected Cohort, , 1998",cited-by,6697128Long-Term Evolution of the Hypervariable Region of Hepatitis C Virus in a Common-Source-Infected Cohort,Long-Term Evolution of the Hypervariable Region of Hepatitis C Virus in a Common-Source-Infected Cohort,"[['JANE', '', 'MCALLISTER'], ['CARMELA', '', 'CASINO'], ['FIONA', '', 'DAVIDSON'], ['JOAN', '', 'POWER'], ['EMER', '', 'LAWLOR'], ['PENG', 'LEE', 'YAP'], ['PETER', '', 'SIMMONDS'], ['DONALD', 'B.', 'SMITH']]",,1998,[]
10.1073/pnas.88.8.3392,"Ray, S., Fanning, L., Wang, X., et. al, Divergent and convergent evolution after a common-source outbreak of hepatitis C virus, , 2005",cited-by,6782247Divergent and convergent evolution after a common-source outbreak of hepatitis C virus,Divergent and convergent evolution after a common-source outbreak of hepatitis C virus,"[['Stuart', 'C.', 'Ray'], ['Liam', '', 'Fanning'], ['Xiao-Hong', '', 'Wang'], ['Dale', 'M.', 'Netski'], ['Elizabeth', '', 'Kenny-Walsh'], ['David', 'L.', 'Thomas']]",,2005,[]
10.1073/pnas.88.8.3392,"NAKAJIMA, N., HIJIKATA, M., YOSHIKURA, H., et. al, Characterization of Long-Term Cultures of Hepatitis C Virus, , 1996",cited-by,14037349Characterization of Long-Term Cultures of Hepatitis C Virus,Characterization of Long-Term Cultures of Hepatitis C Virus,"[['NORIKO', '', 'NAKAJIMA'], ['MINAKO', '', 'HIJIKATA'], ['HIROSHI', '', 'YOSHIKURA'], ['ANDYOHKO', 'K.', 'SHIMIZU']]",,1996,[u'http://jvi.asm.org/cgi/reprint/70/5/3325.pdf']
10.1073/pnas.88.8.3392,"Lesniewski, R., Johnson, R., Scheffel, J., et. al, Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: A new marker of HCV infection closely associated with viremia, Journal of Medical Virology, 1995",cited-by,10.1002/jmv.1890450411,Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: A new marker of HCV infection closely associated with viremia,"[['R.', '', 'Lesniewski'], ['R.', '', 'Johnson'], ['J.', '', 'Scheffel'], ['B.', '', 'Moore'], ['G.', '', 'Okasinski'], ['R.', '', 'Carrick'], ['C.', 'Van', 'Sant'], ['S.', '', 'Desai'], ['I.', '', 'Mushahwar']]",Journal of Medical Virology,1995,[u'http://doi.wiley.com/10.1002/jmv.1890450411']
10.1073/pnas.88.8.3392,"Alter, H., Sanchez-Pescador, R., Urdea, M., et. al, Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA, Journal of Viral Hepatitis, 1995",cited-by,10.1111/j.1365-2893.1995.tb00017.x,Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA,"[['H.', 'J.', 'Alter'], ['R.', '', 'Sanchez-Pescador'], ['M.', 'S.', 'Urdea'], ['J.', 'C.', 'Wilber'], ['R.', 'J.', 'Lagier'], ['A.', 'M.', 'Bisceglie'], ['J.', 'W.', 'Shih'], ['P.', 'D.', 'Neuwald']]",Journal of Viral Hepatitis,1995,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.1995.tb00017.x']
10.1073/pnas.88.8.3392,"Kurosaki, M., Enomoto, N., Marumo, F., et. al, Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection, Hepatology, 1993",cited-by,10.1002/hep.1840180602,Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection,"[['Masayuki', '', 'Kurosaki'], ['Nobuyuki', '', 'Enomoto'], ['Fumiaki', '', 'Marumo'], ['Chifumi', '', 'Sato']]",Hepatology,1993,[u'http://doi.wiley.com/10.1002/hep.1840180602']
10.1073/pnas.88.8.3392,"BASSETT, S., THOMAS, D., BRASKY, K., et. al, Viral Persistence, Antibody to E1 and E2, and Hypervariable Region 1 Sequence Stability in Hepatitis C Virus-Inoculated Chimpanzees, , 1999",cited-by,"13642393Viral Persistence, Antibody to E1 and E2, and Hypervariable Region 1 Sequence Stability in Hepatitis C Virus-Inoculated Chimpanzees","Viral Persistence, Antibody to E1 and E2, and Hypervariable Region 1 Sequence Stability in Hepatitis C Virus-Inoculated Chimpanzees","[['SUZANNE', 'E.', 'BASSETT'], ['DAVID', 'L.', 'THOMAS'], ['KATHLEEN', 'M.', 'BRASKY'], ['ROBERT', 'E.', 'LANFORD']]",,1999,[u'http://jvi.asm.org/cgi/reprint/73/2/1118.pdf']
10.1073/pnas.88.8.3392,"Daghestani, L., Pomeroy, C., , Renal manifestations of hepatitis C infection, American Journal of Medicine, 1999",cited-by,10.1016/S0002-9343(99)00014-5,Renal manifestations of hepatitis C infection,"[['Lena', '', 'Daghestani'], ['Claire', '', 'Pomeroy']]",American Journal of Medicine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0002934399000145', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934399000145']"
10.1073/pnas.88.8.3392,"Wang, Y., Okamoto, H., Tsuda, F., et. al, Prevalence, genotypes, and an isolate (HCC2) of hepatitis C virus in Chinese patients with liver disease, Journal of Medical Virology, 1993",cited-by,10.1002/jmv.1890400316,"Prevalence, genotypes, and an isolate (HCC2) of hepatitis C virus in Chinese patients with liver disease","[['Yu', '', 'Wang'], ['Hiroaki', '', 'Okamoto'], ['Fumio', '', 'Tsuda'], ['Ryozo', '', 'Nagayama'], ['Qi-Min', '', 'Tao'], ['Shunji', '', 'Mishiro']]",Journal of Medical Virology,1993,[u'http://doi.wiley.com/10.1002/jmv.1890400316']
10.1073/pnas.88.8.3392,"Okamoto, H., Kojima, M., Sakamoto, M., et. al, The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease, Journal of General Virology, 1994",cited-by,10.1099/0022-1317-75-3-629,The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease,"[['Hiroaki', '', 'Okamoto'], ['Maki', '', 'Kojima'], ['Minoru', '', 'Sakamoto'], ['Hisao', '', 'Iizuka'], ['Soeliadi', '', 'Hadiwandowo'], ['Sumoharjo', '', 'Suwignyo'], ['Yuzo', '', 'Miyakawa'], ['M.', '', 'Mayumi']]",Journal of General Virology,1994,"[u'http://vir.sgmjournals.org/cgi/reprint/75/3/629.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-75-3-629']"
10.1073/pnas.88.8.3392,"Ludmerer, S., Graham, D., Boots, E., et. al, Replication Fitness and NS5B Drug Sensitivity of Diverse Hepatitis C Virus Isolates Characterized by Using a Transient Replication Assay, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.5.2059-2069.2005,Replication Fitness and NS5B Drug Sensitivity of Diverse Hepatitis C Virus Isolates Characterized by Using a Transient Replication Assay,"[['Steven', 'W.', 'Ludmerer'], ['Donald', 'J.', 'Graham'], ['Evelyn', '', 'Boots'], ['Edward', 'M.', 'Murray'], ['Amy', '', 'Simcoe'], ['Eric', 'J.', 'Markel'], ['Jay', 'A.', 'Grobler'], ['Osvaldo', 'A.', 'Flores'], ['David', 'B.', 'Olsen'], ['Daria', 'J.', 'Hazuda'], ['Robert', 'L.', 'LaFemina']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/5/2059.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.5.2059-2069.2005']"
10.1073/pnas.88.8.3392,"Nakao, H., Okamoto, H., Fukuda, M., et. al, Mutation Rate of GB Virus C/Hepatitis G Virus over the Entire Genome and in Subgenomic Regions, Virology, 1997",cited-by,10.1006/viro.1997.8615,Mutation Rate of GB Virus C/Hepatitis G Virus over the Entire Genome and in Subgenomic Regions,"[['Haruhisa', '', 'Nakao'], ['Hiroaki', '', 'Okamoto'], ['Masako', '', 'Fukuda'], ['Fumio', '', 'Tsuda'], ['Takehiro', '', 'Mitsui'], ['Kazuo', '', 'Masuko'], ['Hisao', '', 'Iizuka'], ['Yuzo', '', 'Miyakawa'], ['Makoto', '', 'Mayumi']]",Virology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0042682297986153', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682297986153']"
10.1073/pnas.88.8.3392,"Ina, Y., Mizokami, M., Ohba, K., et. al, Reduction of synonymous substitutions in the core protein gene of hepatitis C virus, Journal of Molecular Evolution, 1994",cited-by,10.1007/BF00175495,Reduction of synonymous substitutions in the core protein gene of hepatitis C virus,"[['Yasuo', '', 'Ina'], ['Masashi', '', 'Mizokami'], ['Kenichi', '', 'Ohba'], ['Takashi', '', 'Gojobori']]",Journal of Molecular Evolution,1994,"[u'http://www.springerlink.com/index/nw24501h31804w20.pdf', u'http://www.springerlink.com/content/nw24501h31804w20', u'http://www.springerlink.com/index/10.1007/BF00175495', u'http://www.springerlink.com/index/pdf/10.1007/BF00175495']"
10.1073/pnas.88.8.3392,"WEINER, A., PALIARD, X., SELBY, M., et. al, Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity, Journal of Virology, 2001",cited-by,10.1128/JVI.75.15.7142-7148.2001,Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity,"[['AMY', 'J.', 'WEINER'], ['XAVIER', '', 'PALIARD'], ['MARK', 'J.', 'SELBY'], ['ANGELICA', '', 'MEDINA-SELBY'], ['DORIS', '', 'COIT'], ['STEVE', '', 'NGUYEN'], ['JOE', '', 'KANSOPON'], ['CHRISTOPHER', 'L.', 'ARIAN'], ['PHILIP', '', 'NG'], ['JEFFERY', '', 'TUCKER'], ['CHUN-TING', '', 'LEE'], ['NOELLE', 'K.', 'POLAKOS'], ['JANG', '', 'HAN'], ['SHIRLEY', '', 'WONG'], ['HUI-HUA', '', 'LU'], ['STEVE', '', 'ROSENBERG'], ['KATHY', 'M.', 'BRASKY'], ['DAVID', '', 'CHIEN'], ['GEORGE', '', 'KUO'], ['M.', '', 'Houghton']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.15.7142-7148.2001', u'http://jvi.asm.org/cgi/reprint/75/15/7142.pdf']"
10.1073/pnas.88.8.3392,"Chang, K., Rehermann, B., Chisari, F., , Immunopathology of hepatitis C, Springer Seminars in Immunopathology, 1997",cited-by,10.1007/BF00945025,Immunopathology of hepatitis C,"[['Kyong-Mi', '', 'Chang'], ['Barbara', '', 'Rehermann'], ['Francis', 'V.', 'Chisari']]",Springer Seminars in Immunopathology,1997,"[u'http://www.springerlink.com/index/g7584j0081412582.pdf', u'http://www.springerlink.com/content/g7584j0081412582', u'http://www.springerlink.com/index/10.1007/BF00945025', u'http://www.springerlink.com/index/pdf/10.1007/BF00945025']"
10.1073/pnas.88.8.3392,"Smith, D., Simmonds, P., , Characteristics of Nucleotide Substitution in the Hepatitis C Virus Genome: Constraints on Sequence Change in Coding Regions at Both Ends of the Genome, Journal of Molecular Evolution, 1997",cited-by,10.1007/PL00006226,Characteristics of Nucleotide Substitution in the Hepatitis C Virus Genome: Constraints on Sequence Change in Coding Regions at Both Ends of the Genome,"[['Donald', 'B.', 'Smith'], ['Peter', '', 'Simmonds']]",Journal of Molecular Evolution,1997,"[u'http://www.springerlink.com/index/vljplqraw2pgm53n.pdf', u'http://www.springerlink.com/content/vljplqraw2pgm53n', u'http://www.springerlink.com/index/10.1007/PL00006226', u'http://www.springerlink.com/index/pdf/10.1007/PL00006226']"
10.1073/pnas.88.8.3392,"Tokita, H., Okamoto, H., Luengrojanakul, P., et. al, Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups, Journal of General Virology, 1995",cited-by,10.1099/0022-1317-76-9-2329,"Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups","[['Hajime', '', 'Tokita'], ['Hiroaki', '', 'Okamoto'], ['Pairoj', '', 'Luengrojanakul'], ['Kriengsak', '', 'Vareesangthip'], ['Termchai', '', 'Chainuvati'], ['Hisao', '', 'Iizuka'], ['Furaio', '', 'Tsuda'], ['Yuzo', '', 'Miyakawa'], ['M.', '', 'Mayumi']]",Journal of General Virology,1995,"[u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-76-9-2329', u'http://vir.sgmjournals.org/cgi/reprint/76/9/2329.pdf']"
10.1073/pnas.88.8.3392,"Chayama, K., Kobayashi, M., Tsubota, A., et. al, Molecular analysis of intraspousal transmission of hepatitis C virus, Journal of Hepatology, 1995",cited-by,10.1016/0168-8278(95)80106-5,Molecular analysis of intraspousal transmission of hepatitis C virus,"[['Kazuaki', '', 'Chayama'], ['Mariko', '', 'Kobayashi'], ['Akihito', '', 'Tsubota'], ['Isao', '', 'Koida'], ['Yasuji', '', 'Arase'], ['Satoshi', '', 'Saitoh'], ['Kenji', '', 'Ikeda'], ['Hiromitsu', '', 'Kumada']]",Journal of Hepatology,1995,"[u'http://www.sciencedirect.com/science/article/pii/0168827895801065', u'http://linkinghub.elsevier.com/retrieve/pii/0168827895801065']"
10.1073/pnas.88.8.3392,"Chang, K., , Immunopathogenesis of hepatitis C virus infection, Clinics in Liver Disease, 2003",cited-by,10.1016/S1089-3261(02)00068-5,Immunopathogenesis of hepatitis C virus infection,"[['Kyong-Mi', '', 'Chang']]",Clinics in Liver Disease,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1089326102000685', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326102000685']"
10.1073/pnas.88.8.3392,"SULLIVAN, D., WILSON, J., CARITHERS, R., et. al, Multigene Tracking of Hepatitis C Virus Quasispecies after Liver Transplantation: Correlation of Genetic Diversification in the Envelope Region with Asymptomatic or Mild Disease Patterns, , 1998",cited-by,11172057Multigene Tracking of Hepatitis C Virus Quasispecies after Liver Transplantation: Correlation of Genetic Diversification in the Envelope Region with Asymptomatic or Mild Disease Patterns,Multigene Tracking of Hepatitis C Virus Quasispecies after Liver Transplantation: Correlation of Genetic Diversification in the Envelope Region with Asymptomatic or Mild Disease Patterns,"[['DANIEL', 'G.', 'SULLIVAN'], ['JEFFREY', 'J.', 'WILSON'], ['ROBERT', 'L.', 'CARITHERS'], ['JAMES', 'D.', 'PERKINS'], ['DAVID', 'R.', 'GRETCH']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/12/10036.pdf']
10.1073/pnas.88.8.3392,"Pavio, N., Lai, M., , The hepatitis C virus persistence: how to evade the immune system?, Journal of Biosciences, 2003",cited-by,10.1007/BF02970148,The hepatitis C virus persistence: how to evade the immune system?,"[['Nicole', '', 'Pavio'], ['Michael', 'M. C.', 'Lai']]",Journal of Biosciences,2003,"[u'http://www.springerlink.com/index/k6x201p3646mt542.pdf', u'http://www.springerlink.com/content/k6x201p3646mt542', u'http://www.springerlink.com/index/10.1007/BF02970148', u'http://www.springerlink.com/index/pdf/10.1007/BF02970148']"
10.1073/pnas.88.8.3392,"RAY, S., MAO, Q., LANFORD, R., et. al, Hypervariable Region 1 Sequence Stability during Hepatitis C Virus Replication in Chimpanzees, Journal of Virology, 2000",cited-by,10.1128/JVI.74.7.3058-3066.2000,Hypervariable Region 1 Sequence Stability during Hepatitis C Virus Replication in Chimpanzees,"[['STUART', 'C.', 'RAY'], ['QING', '', 'MAO'], ['ROBERT', 'E.', 'LANFORD'], ['SUZANNE', '', 'BASSETT'], ['OLIVER', '', 'LAEYENDECKER'], ['YU-MING', '', 'WANG'], ['DAVID', 'L.', 'THOMAS']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/7/3058.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.7.3058-3066.2000']"
10.1073/pnas.88.8.3392,"Farci, P., Bukh, J., Purcell, R., , The quasispecies of hepatitis C virus and the host immune response, Springer Seminars in Immunopathology, 1997",cited-by,10.1007/BF00945022,The quasispecies of hepatitis C virus and the host immune response,"[['Patrizia', '', 'Farci'], ['Jens', '', 'Bukh'], ['Robert', 'H.', 'Purcell']]",Springer Seminars in Immunopathology,1997,"[u'http://www.springerlink.com/content/g8698767t406431q', u'http://www.springerlink.com/index/g8698767t406431q.pdf', u'http://www.springerlink.com/index/10.1007/BF00945022', u'http://www.springerlink.com/index/pdf/10.1007/BF00945022']"
10.1073/pnas.88.8.3392,"Abe, K., Inchauspe, G., Fujisawa, K., , Genomic Characterization and Mutation Rate of Hepatitis C Virus Isolated From a Patient Who Contracted Hepatitis During an Epidemic of nonA, non-B Hepatitis in Japan, Journal of General Virology, 1992",cited-by,10.1099/0022-1317-73-10-2725,"Genomic Characterization and Mutation Rate of Hepatitis C Virus Isolated From a Patient Who Contracted Hepatitis During an Epidemic of nonA, non-B Hepatitis in Japan","[['Kenji', '', 'Abe'], ['G.', '', 'Inchauspe'], ['K.', '', 'Fujisawa']]",Journal of General Virology,1992,"[u'http://vir.sgmjournals.org/cgi/reprint/73/10/2725.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-73-10-2725']"
10.1073/pnas.88.8.3392,"Malet, I., Belnard, M., Agut, H., et. al, From RNA to quasispecies: a DNA polymerase with proofreading activity is highly recommended for accurate assessment of viral diversity, Journal of Virological Methods, 2003",cited-by,10.1016/S0166-0934(03)00067-3,From RNA to quasispecies: a DNA polymerase with proofreading activity is highly recommended for accurate assessment of viral diversity,"[['Isabelle', '', 'Malet'], ['Magali', '', 'Belnard'], ['Henri', '', 'Agut'], ['Annie', '', 'Cahour']]",Journal of Virological Methods,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0166093403000673', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093403000673']"
10.1073/pnas.88.8.3392,"Sekiya, H., Kato, N., Ootsuyama, Y., et. al, Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: Humoral immune response to hypervariable region 1, International Journal of Cancer, 1994",cited-by,10.1002/ijc.2910570509,Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: Humoral immune response to hypervariable region 1,"[['Hitomi', '', 'Sekiya'], ['Nobuyuki', '', 'Kato'], ['Yuko', '', 'Ootsuyama'], ['Takahide', '', 'Nakazawa'], ['Katsumi', '', 'Yamauchi'], ['Kunitada', '', 'Shimotohno']]",International Journal of Cancer,1994,[u'http://doi.wiley.com/10.1002/ijc.2910570509']
10.1073/pnas.88.8.3392,"Freeman, A., Marinos, G., Ffrench, R., et. al, Immunopathogenesis of hepatitis C virus infection, Immunology and Cell Biology, 2001",cited-by,10.1046/j.1440-1711.2001.01036.x,Immunopathogenesis of hepatitis C virus infection,"[['Anthony', 'J', 'Freeman'], ['George', '', 'Marinos'], ['Rosemary', 'A', 'Ffrench'], ['Andrew', 'R', 'Lloyd']]",Immunology and Cell Biology,2001,"[u'http://www.nature.com/doifinder/10.1046/j.1440-1711.2001.01036.x', u'http://dx.doi.org/10.1046/j.1440-1711.2001.01036.x']"
10.1073/pnas.88.8.3392,"WYATT, C., ANDRUS, L., BROTMAN, B., et. al, Immunity in Chimpanzees Chronically Infected with Hepatitis C Virus: Role of Minor Quasispecies in Reinfection, , 1998",cited-by,6805189Immunity in Chimpanzees Chronically Infected with Hepatitis C Virus: Role of Minor Quasispecies in Reinfection,Immunity in Chimpanzees Chronically Infected with Hepatitis C Virus: Role of Minor Quasispecies in Reinfection,"[['COLBY', 'A.', 'WYATT'], ['LINDA', '', 'ANDRUS'], ['BETSY', '', 'BROTMAN'], ['FANNIE', '', 'HUANG'], ['DONG-HUN', '', 'LEE'], ['ALFRED', 'M.', 'PRINCE']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/3/1725.pdf']
10.1073/pnas.88.8.3392,"Patel, A., Wood, J., Penin, F., et. al, Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding, , 2000",cited-by,6749172Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding,Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding,"[['Arvind', 'H.', 'Patel'], ['Jonny', '', 'Wood'], ['Francois', '', 'Penin'], ['Jean', '', 'Dubuisson'], ['J.', 'A.', 'McKeating']]",,2000,[]
10.1073/pnas.88.8.3392,"HAHM, B., HAN, D., BACK, S., et. al, NS3-4A of Hepatitis C Virus Is a Chymotrypsin-Like Protease, , 1995",cited-by,14202164NS3-4A of Hepatitis C Virus Is a Chymotrypsin-Like Protease,NS3-4A of Hepatitis C Virus Is a Chymotrypsin-Like Protease,"[['BUMSUK', '', 'HAHM'], ['DAE', 'SUNG', 'HAN'], ['SUNG', 'HOON', 'BACK'], ['OK-KYU', '', 'SONG'], ['MYUNG-JAE', '', 'CHO'], ['CHUL-JOONG', '', 'KIM'], ['KUNITADA', '', 'SHIMOTOHNO'], ['ANDSUNG', 'KEY', 'JANG']]",,1995,[u'http://jvi.asm.org/cgi/reprint/69/4/2534.pdf']
10.1073/pnas.88.8.3392,"SCARSELLI, E., CERINO, A., ESPOSITO, G., et. al, Occurrence of Antibodies Reactive with More than One Variant of the Putative Envelope Glycoprotein (gp70) Hypervariable Region 1 in Viremic Hepatitis C Virus-Infected Patients, , 1995",cited-by,14017983Occurrence of Antibodies Reactive with More than One Variant of the Putative Envelope Glycoprotein (gp70) Hypervariable Region 1 in Viremic Hepatitis C Virus-Infected Patients,Occurrence of Antibodies Reactive with More than One Variant of the Putative Envelope Glycoprotein (gp70) Hypervariable Region 1 in Viremic Hepatitis C Virus-Infected Patients,"[['ELISA', '', 'SCARSELLI'], ['ANTONELLA', '', 'CERINO'], ['GLORIA', '', 'ESPOSITO'], ['ENRICO', '', 'SILINI'], ['MARIO', 'U.', 'MONDELLI'], ['ANDCINZIA', '', 'TRABONI']]",,1995,[u'http://jvi.asm.org/cgi/reprint/69/7/4407.pdf']
10.1073/pnas.88.8.3392,"Höhne, M., Schreier, E., Roggendorf, M., , Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak, Archives of Virology, 1994",cited-by,10.1007/BF01311170,Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak,"[['M.', '', 'H\xc3\xb6hne'], ['E.', '', 'Schreier'], ['M.', '', 'Roggendorf']]",Archives of Virology,1994,"[u'http://www.springerlink.com/content/x5484p5836860447', u'http://www.springerlink.com/index/x5484p5836860447.pdf', u'http://www.springerlink.com/index/10.1007/BF01311170', u'http://www.springerlink.com/index/pdf/10.1007/BF01311170']"
10.1073/pnas.88.8.3392,"Frelin, L., Ahlén, G., Alheim, M., et. al, Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene, Gene Therapy, 2004",cited-by,10.1038/sj.gt.3302184,Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene,"[['L', '', 'Frelin'], ['G', '', 'Ahl\xc3\xa9n'], ['M', '', 'Alheim'], ['O', '', 'Weiland'], ['C', '', 'Barnfield'], ['P', '', 'Liljestr\xc3\xb6m'], ['M', '', 'S\xc3\xa4llberg']]",Gene Therapy,2004,"[u'http://www.nature.com/doifinder/10.1038/sj.gt.3302184', u'http://dx.doi.org/10.1038/sj.gt.3302184']"
10.1073/pnas.88.8.3392,"Hayashi, J., Aoki, H., Arakawa, Y., et. al, Hepatitis C Virus and Hepatocarcinogenesis, Intervirology, 1999",cited-by,10.1159/000024962,Hepatitis C Virus and Hepatocarcinogenesis,"[['Junpei', '', 'Hayashi'], ['Hiroshi', '', 'Aoki'], ['Yasuyuki', '', 'Arakawa'], ['Okio', '', 'Hino']]",Intervirology,1999,"[u'http://www.online.karger.com/doi/10.1159/000024962', u'http://www.karger.com/doi/10.1159/000024962']"
10.1073/pnas.88.8.3392,"Kwong, A., Kim, J., Rao, G., et. al, Hepatitis C virus NS3/4A protease, Antiviral Research, 1998",cited-by,10.1016/S0166-3542(98)00043-6,Hepatitis C virus NS3/4A protease,"[['Ann', 'D', 'Kwong'], ['Joseph', 'L', 'Kim'], ['Govinda', '', 'Rao'], ['Dasa', '', 'Lipovsek'], ['Scott', 'A', 'Raybuck']]",Antiviral Research,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0166354298000436', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354298000436']"
10.1073/pnas.88.8.3392,"Koziel, M., Walker, B., , Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection, Springer Seminars in Immunopathology, 1997",cited-by,10.1007/BF00945026,Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection,"[['Margaret', 'J.', 'Koziel'], ['Bruce', 'D.', 'Walker']]",Springer Seminars in Immunopathology,1997,"[u'http://www.springerlink.com/content/k0540126h3071065', u'http://www.springerlink.com/index/k0540126h3071065.pdf', u'http://www.springerlink.com/index/10.1007/BF00945026', u'http://www.springerlink.com/index/pdf/10.1007/BF00945026']"
10.1073/pnas.88.8.3392,"Lutchman, G., Danehower, S., Liang, T., et. al, Mutation Rate of the Hepatitis C Virus NS5B in Patients Undergoing Treatment With Ribavirin Monotherapy, Gastroenterology, 2007",cited-by,10.1053/j.gastro.2007.03.035,Mutation Rate of the Hepatitis C Virus NS5B in Patients Undergoing Treatment With Ribavirin Monotherapy,"[['Glen', '', 'Lutchman'], ['Susan', '', 'Danehower'], ['T.', 'Jake', 'Liang'], ['Jay', 'H.', 'Hoofnagle'], ['Michael', '', 'Thomson'], ['Marc', 'G.', 'Ghany']]",Gastroenterology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0016508507005598', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508507005598']"
10.1073/pnas.88.8.3392,"Laskus, T., Wilkinson, J., Gallegos-Orozco, J., et. al, Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2004.06.005,Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion,"[['Tomasz', '', 'Laskus'], ['Jeffrey', '', 'Wilkinson'], ['Juan', 'F.', 'Gallegos-Orozco'], ['Marek', '', 'Radkowski'], ['Debra', 'M.', 'Adair'], ['Marek', '', 'Nowicki'], ['Eva', '', 'Operskalski'], ['Zelma', '', 'Buskell'], ['Leonard', 'B.', 'Seeff'], ['Hugo', '', 'Vargas'], ['Jorge', '', 'Rakela']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508504010248', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508504010248']"
10.1073/pnas.88.8.3392,"Walker, C., , Comparative features of hepatitis C virus infection in humans and chimpanzees, Springer Seminars in Immunopathology, 1997",cited-by,10.1007/BF00945027,Comparative features of hepatitis C virus infection in humans and chimpanzees,"[['Christopher', 'M.', 'Walker']]",Springer Seminars in Immunopathology,1997,"[u'http://www.springerlink.com/content/kg6q7855175ukx07', u'http://www.springerlink.com/index/kg6q7855175ukx07.pdf', u'http://www.springerlink.com/index/10.1007/BF00945027', u'http://www.springerlink.com/index/pdf/10.1007/BF00945027']"
10.1073/pnas.88.8.3392,"Mizokami, M., Gojobori, T., Ohba, K., et. al, Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes, Journal of Hepatology, 1996",cited-by,10.1016/S0168-8278(96)80149-8,"Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes","[['Masashi', '', 'Mizokami'], ['Takashi', '', 'Gojobori'], ['Ken-ichi', '', 'Ohba'], ['Kazuho', '', 'Ikeo'], ['Xian-Ming', '', 'Ge'], ['Tomoyoshi', '', 'Ohno'], ['Etsuro', '', 'Orito'], ['Johnson', 'Y. N.', 'Lau']]",Journal of Hepatology,1996,"[u'http://www.sciencedirect.com/science/article/pii/S0168827896801498', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827896801498']"
10.1073/pnas.88.8.3392,"Lesniewski, R., Boardway, K., Casey, J., et. al, Hypervariable 5′-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants, Journal of Medical Virology, 1993",cited-by,10.1002/jmv.1890400213,Hypervariable 5′-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants,"[['Richard', 'R.', 'Lesniewski'], ['Keith', 'M.', 'Boardway'], ['James', 'M.', 'Casey'], ['Suresh', 'M.', 'Desai'], ['Sushil', 'G.', 'Devare'], ['Tat', 'K.', 'Leung'], ['Isa', 'K.', 'Mushahwar']]",Journal of Medical Virology,1993,[u'http://doi.wiley.com/10.1002/jmv.1890400213']
10.1073/pnas.88.8.3392,"Simmonds, P., , Variability of hepatitis C virus, Hepatology, 1995",cited-by,10.1002/hep.1840210243,Variability of hepatitis C virus,"[['Peter', '', 'Simmonds']]",Hepatology,1995,[u'http://doi.wiley.com/10.1002/hep.1840210243']
10.1073/pnas.88.8.3392,"Magrin, S., Craxi, A., Fabiano, C., et. al, Serum hepatitis C virus (HCV)RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis, Journal of Medical Virology, 1992",cited-by,10.1002/jmv.1890380309,Serum hepatitis C virus (HCV)RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis,"[['S.', '', 'Magrin'], ['A.', '', 'Craxi'], ['C.', '', 'Fabiano'], ['G.', '', 'Fiorentino'], ['L.', '', 'Marino'], ['P.', '', 'Almasio'], ['G.', 'B.', 'Pinzello'], ['U.', '', 'Palazzo'], ['M.', '', 'Vitale'], ['A.', '', 'Maggio'], ['G.', '', 'Bucca'], ['F.', '', 'Gianguzza'], ['V.', '', 'Shyamala'], ['J.', 'H.', 'Han'], ['L.', '', 'Pagliaro']]",Journal of Medical Virology,1992,[u'http://doi.wiley.com/10.1002/jmv.1890380309']
10.1073/pnas.88.8.3392,"Yoshioka, K., Higashi, Y., Yamada, M., et. al, Predictive factors in the response to interferon therapy in chronic hepatitis C, Liver, 2008",cited-by,10.1111/j.1600-0676.1995.tb00108.x,Predictive factors in the response to interferon therapy in chronic hepatitis C,"[['Kentaro', '', 'Yoshioka'], ['Yasuyuki', '', 'Higashi'], ['Masaki', '', 'Yamada'], ['Toshiyuki', '', 'Aiyama'], ['Masahiro', '', 'Takayanagi'], ['Kazuma', '', 'Tanaka'], ['Akihiko', '', 'Okumura'], ['Kazuo', '', 'Iwata'], ['Shinichi', '', 'Kakumu']]",Liver,2008,[u'http://doi.wiley.com/10.1111/j.1600-0676.1995.tb00108.x']
10.1073/pnas.88.8.3392,"Domingo, E., Gomez, J., , Quasispecies and its impact on viral hepatitis, Virus Research, 2007",cited-by,10.1016/j.virusres.2007.02.001,Quasispecies and its impact on viral hepatitis,"[['Esteban', '', 'Domingo'], ['Jordi', '', 'Gomez']]",Virus Research,2007,"[u'http://www.sciencedirect.com/science/article/pii/S016817020700041X', u'http://linkinghub.elsevier.com/retrieve/pii/S016817020700041X']"
10.1073/pnas.88.8.3392,"Ikeda, M., Kato, N., Mizutani, T., et. al, Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes, Journal of Hepatology, 1997",cited-by,10.1016/S0168-8278(97)80347-9,Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes,"[['Masanori', '', 'Ikeda'], ['Nobuyuki', '', 'Kato'], ['Tetsuya', '', 'Mizutani'], ['Kazuo', '', 'Sugiyama'], ['Katsuaki', '', 'Tanaka'], ['Kunitada', '', 'Shimotohno']]",Journal of Hepatology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0168827897803479', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827897803479']"
10.1073/pnas.88.8.3392,"Dusheiko, G., Simmonds, P., , Sequence variability of hepatitis C virus and its clinical relevance, Journal of Viral Hepatitis, 1994",cited-by,10.1111/j.1365-2893.1994.tb00057.x,Sequence variability of hepatitis C virus and its clinical relevance,"[['G.', '', 'Dusheiko'], ['P.', '', 'Simmonds']]",Journal of Viral Hepatitis,1994,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.1994.tb00057.x']
10.1073/pnas.88.8.3392,"Lin, H., Shi, N., Mizokami, M., et. al, Polymerase chain reaction assay for hepatitis C virus RNA using a single tube for reverse transcription and serial rounds of amplification with nested primer pairs, Journal of Medical Virology, 1992",cited-by,10.1002/jmv.1890380312,Polymerase chain reaction assay for hepatitis C virus RNA using a single tube for reverse transcription and serial rounds of amplification with nested primer pairs,"[['Hsiang', 'Ju', 'Lin'], ['Naiyi', '', 'Shi'], ['Masashi', '', 'Mizokami'], ['F.', 'Blaine', 'Hollinger']]",Journal of Medical Virology,1992,[u'http://doi.wiley.com/10.1002/jmv.1890380312']
10.1073/pnas.88.8.3392,"Zeuzem, S., Scheuermann, E., Waschk, D., et. al, Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients, Kidney International, 1996",cited-by,10.1038/ki.1996.123,Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients,"[['Stefan', '', 'Zeuzem'], ['Ernst', 'H', 'Scheuermann'], ['Dorothee', '', 'Waschk'], ['Jung-Hun', '', 'Lee'], ['Christof', '', 'Blaser'], ['Alexa', '', 'Franke'], ['W', 'Kurt', 'Roth']]",Kidney International,1996,"[u'http://dx.doi.org/10.1038/ki.1996.123', u'http://www.nature.com/doifinder/10.1038/ki.1996.123']"
10.1073/pnas.88.8.3392,"HU, Y., BALASKAS, E., FURIONE, M., et. al, Comparison and Application of a Novel Genotyping Method, Semiautomated Primer-Specific and Mispair Extension Analysis, and Four Other Genotyping Assays for Detection of Hepatitis C Virus Mixed-Genotype Infections, , 2000",cited-by,"13922164Comparison and Application of a Novel Genotyping Method, Semiautomated Primer-Specific and Mispair Extension Analysis, and Four Other Genotyping Assays for Detection of Hepatitis C Virus Mixed-Genotype Infections","Comparison and Application of a Novel Genotyping Method, Semiautomated Primer-Specific and Mispair Extension Analysis, and Four Other Genotyping Assays for Detection of Hepatitis C Virus Mixed-Genotype Infections","[['YU-WEN', '', 'HU'], ['EVAN', '', 'BALASKAS'], ['MILENA', '', 'FURIONE'], ['PEI-HUA', '', 'YEN'], ['GARRY', '', 'KESSLER'], ['VITO', '', 'SCALIA'], ['LINDA', '', 'CHUI'], ['GRAHAM', '', 'SHER']]",,2000,[u'http://jcm.asm.org/cgi/reprint/38/8/2807.pdf']
10.1073/pnas.88.8.3392,"Caporaso, N., Ascione, A., Stroffolini, T., , Spread of hepatitis C virus infection within families, Journal of Viral Hepatitis, 1998",cited-by,10.1046/j.1365-2893.1998.00085.x,Spread of hepatitis C virus infection within families,"[['N.', '', 'Caporaso'], ['A.', '', 'Ascione'], ['T.', '', 'Stroffolini']]",Journal of Viral Hepatitis,1998,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.1998.00085.x']
10.1073/pnas.88.8.3392,"TELLIER, R., BUKH, J., EMERSON, S., et. al, Long PCR and Its Application to Hepatitis Viruses: Amplification of Hepatitis A, Hepatitis B, and Hepatitis C Virus Genomes, , 1996",cited-by,"14005684Long PCR and Its Application to Hepatitis Viruses: Amplification of Hepatitis A, Hepatitis B, and Hepatitis C Virus Genomes","Long PCR and Its Application to Hepatitis Viruses: Amplification of Hepatitis A, Hepatitis B, and Hepatitis C Virus Genomes","[['RAYMOND', '', 'TELLIER'], ['JENS', '', 'BUKH'], ['SUZANNE', 'U.', 'EMERSON'], ['ROGER', 'H.', 'MILLER'], ['ANDROBERT', 'H.', 'PURCELL']]",,1996,[u'http://jcm.asm.org/cgi/reprint/34/12/3085.pdf']
10.1073/pnas.88.8.3392,"Lloyd, A., Jagger, E., Post, J., et. al, Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection, Immunology and Cell Biology, 2007",cited-by,10.1038/sj.icb.7100010,Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection,"[['Andrew', 'R', 'Lloyd'], ['Emma', '', 'Jagger'], ['Jeffrey', 'J', 'Post'], ['Lee-Ann', '', 'Crooks'], ['William', 'D', 'Rawlinson'], ['Young', 'S', 'Hahn'], ['Rosemary', 'A', 'Ffrench']]",Immunology and Cell Biology,2007,"[u'http://www.nature.com/doifinder/10.1038/sj.icb.7100010', u'http://dx.doi.org/10.1038/sj.icb.7100010']"
10.1073/pnas.88.8.3392,"Frelin, L., Alheim, M., Chen, A., et. al, Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo, Gene Therapy, 2003",cited-by,10.1038/sj.gt.3301933,Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo,"[['L', '', 'Frelin'], ['M', '', 'Alheim'], ['A', '', 'Chen'], ['J', '', 'S\xc3\xb6derholm'], ['B', '', 'Rozell'], ['C', '', 'Barnfield'], ['P', '', 'Liljestr\xc3\xb6m'], ['M', '', 'S\xc3\xa4llberg']]",Gene Therapy,2003,"[u'http://www.nature.com/doifinder/10.1038/sj.gt.3301933', u'http://dx.doi.org/10.1038/sj.gt.3301933']"
10.1073/pnas.88.8.3392,"BUGLI, F., MANCINI, N., KANG, C., et. al, Mapping B-Cell Epitopes of Hepatitis C Virus E2 Glycoprotein Using Human Monoclonal Antibodies from Phage Display Libraries, Journal of Virology, 2001",cited-by,10.1128/JVI.75.20.9986-9990.2001,Mapping B-Cell Epitopes of Hepatitis C Virus E2 Glycoprotein Using Human Monoclonal Antibodies from Phage Display Libraries,"[['FRANCESCA', '', 'BUGLI'], ['NICASIO', '', 'MANCINI'], ['CHANG-YUIL', '', 'KANG'], ['CRISTIANA', 'DI', 'CAMPLI'], ['ANTONELLA', '', 'GRIECO'], ['ALDO', '', 'MANZIN'], ['ARMANDO', '', 'GABRIELLI'], ['ANTONIO', '', 'GASBARRINI'], ['GIOVANNI', '', 'FADDA'], ['PIETRO', 'E.', 'VARALDO'], ['MASSIMO', '', 'CLEMENTI'], ['ROBERTO', '', 'BURIONI']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/20/9986.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.20.9986-9990.2001']"
10.1073/pnas.88.8.3392,"Hamaia, S., Li, C., Allain, J., , The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines, , 2001",cited-by,6706593The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines,The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines,"[['Samir', '', 'Hamaia'], ['Chengyao', '', 'Li'], ['Jean-Pierre', '', 'Allain']]",,2001,[]
10.1073/pnas.88.8.3392,"Ukita, M., Okamoto, H., Nishizawa, T., et. al, The entire nucleotide sequences of two distinct TT virus (TTV) isolates (TJN01 and TJN02) remotely related to the original TTV isolates, Archives of Virology, 2000",cited-by,10.1007/s007050070075,The entire nucleotide sequences of two distinct TT virus (TTV) isolates (TJN01 and TJN02) remotely related to the original TTV isolates,"[['M.', '', 'Ukita'], ['H.', '', 'Okamoto'], ['T.', '', 'Nishizawa'], ['A.', '', 'Tawara'], ['M.', '', 'Takahashi'], ['H.', '', 'Iizuka'], ['Y.', '', 'Miyakawa'], ['M.', '', 'Mayumi']]",Archives of Virology,2000,"[u'http://www.springerlink.com/content/0hctuwb8ucwjcl2x', u'http://www.springerlink.com/index/0hctuwb8ucwjcl2x.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s007050070075', u'http://www.springerlink.com/index/pdf/10.1007/s007050070075']"
10.1073/pnas.88.8.3392,"Smith, D., Basaras, M., Frost, S., et. al, Phylogenetic analysis of GBV-C/hepatitis G virus, , 2000",cited-by,6904370Phylogenetic analysis of GBV-C/hepatitis G virus,Phylogenetic analysis of GBV-C/hepatitis G virus,"[['Donald', 'B.', 'Smith'], ['Miren', '', 'Basaras'], ['Simon', '', 'Frost'], ['Dan', '', 'Haydon'], ['Narcisa', '', 'Cuceanu'], ['Linda', '', 'Prescott'], ['Cara', '', 'Kamenka'], ['David', '', 'Millband'], ['Mahomed', 'A.', 'Sathar'], ['Peter', '', 'Simmonds']]",,2000,[u'http://vir.sgmjournals.org/cgi/reprint/81/3/769.pdf']
10.1073/pnas.88.8.3392,"Greene, W., Cheong, M., Ng, V., et. al, Prevalence of hepatitis C virus sequence variants in south-east Asia, Journal of General Virology, 1995",cited-by,10.1099/0022-1317-76-1-211,Prevalence of hepatitis C virus sequence variants in south-east Asia,"[['W.', 'K.', 'Greene'], ['M.', 'K.', 'Cheong'], ['V.', '', 'Ng'], ['K.', 'W.', 'Yap']]",Journal of General Virology,1995,"[u'http://vir.sgmjournals.org/cgi/reprint/76/1/211.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-76-1-211']"
10.1073/pnas.88.8.3392,"Webster, D., Klenerman, P., Collier, J., et. al, Development of novel treatments for hepatitis C, Lancet Infectious Diseases, 2009",cited-by,10.1016/S1473-3099(09)70020-9,Development of novel treatments for hepatitis C,"[['Daniel', 'P', 'Webster'], ['Paul', '', 'Klenerman'], ['Jane', '', 'Collier'], ['Katie', 'JM', 'Jeffery']]",Lancet Infectious Diseases,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1473309909700209', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309909700209']"
10.1073/pnas.88.8.3392,", Q., , N., , L., , Hepatitis C virus mixed genotype infection in patients on haemodialysis, Journal of Viral Hepatitis, 2000",cited-by,10.1046/j.1365-2893.2000.00208.x,Hepatitis C virus mixed genotype infection in patients on haemodialysis,"[['Qian', '', ''], ['Natov', '', ''], ['Lau', '', '']]",Journal of Viral Hepatitis,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2000.00208.x']
10.1073/pnas.88.8.3392,"SMITH, D., SIMMONDS, P., , Review: Molecular epidemiology of hepatitis C virus, Journal of Gastroenterology and Hepatology, 1997",cited-by,10.1111/j.1440-1746.1997.tb00477.x,Review: Molecular epidemiology of hepatitis C virus,"[['DONALD', 'B', 'SMITH'], ['PETER', '', 'SIMMONDS']]",Journal of Gastroenterology and Hepatology,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.1997.tb00477.x']
10.1073/pnas.88.8.3392,"Sakamoto, N., Enomoto, N., Kurosaki, M., et. al, Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection, Journal of Medical Virology, 1994",cited-by,10.1002/jmv.1890420119,Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection,"[['Naoya', '', 'Sakamoto'], ['Nobuyuki', '', 'Enomoto'], ['Masayuki', '', 'Kurosaki'], ['Fumiaki', '', 'Marumo'], ['Chifumi', '', 'Sato']]",Journal of Medical Virology,1994,[u'http://doi.wiley.com/10.1002/jmv.1890420119']
10.1073/pnas.88.8.3392,"Ohno, T., Mizokami, M., Tibbs, C., et. al, New genotype of hepatitis C virus in South Africa, Journal of Medical Virology, 1994",cited-by,10.1002/jmv.1890420414,New genotype of hepatitis C virus in South Africa,"[['T.', '', 'Ohno'], ['M.', '', 'Mizokami'], ['C.', 'J.', 'Tibbs'], ['K.', '', 'Ohba'], ['K.', '', 'Suzuki'], ['R.-R.', '', 'Wu'], ['K.', 'T.', 'Nouri-Aria'], ['Roger', '', 'Williams']]",Journal of Medical Virology,1994,[u'http://doi.wiley.com/10.1002/jmv.1890420414']
10.1073/pnas.88.8.3392,"Smith, D., , Evolution of the hypervariable region of hepatitis C virus, Journal of Viral Hepatitis, 1999",cited-by,10.1046/j.1365-2893.1999.00010.x,Evolution of the hypervariable region of hepatitis C virus,"[['D.', 'B.', 'Smith']]",Journal of Viral Hepatitis,1999,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.1999.00010.x']
10.1073/pnas.88.8.3392,"Yi, M., Nakamoto, Y., Kaneko, S., et. al, Delineation of Regions Important for Heteromeric Association of Hepatitis C Virus E1 and E2, Virology, 1997",cited-by,10.1006/viro.1997.8516,Delineation of Regions Important for Heteromeric Association of Hepatitis C Virus E1 and E2,"[['Minkyung', '', 'Yi'], ['Yasunari', '', 'Nakamoto'], ['Shuichi', '', 'Kaneko'], ['Tatsuya', '', 'Yamashita'], ['Seishi', '', 'Murakami']]",Virology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0042682297985160', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682297985160']"
10.1073/pnas.88.8.3392,"Watanabe, T., Umehara, T., Kohara, M., , Therapeutic application of RNA interference for hepatitis C virus, Advanced Drug Delivery Reviews, 2007",cited-by,10.1016/j.addr.2007.03.022,Therapeutic application of RNA interference for hepatitis C virus,"[['Tsunamasa', '', 'Watanabe'], ['Takuya', '', 'Umehara'], ['Michinori', '', 'Kohara']]",Advanced Drug Delivery Reviews,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0169409X07001305', u'http://linkinghub.elsevier.com/retrieve/pii/S0169409X07001305']"
10.1073/pnas.88.8.3392,"Katsoulidou, A., Sypsa, V., Tassopoulos, N., et. al, Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2005.00649.x,Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates,"[['A.', '', 'Katsoulidou'], ['V.', '', 'Sypsa'], ['N.', 'C.', 'Tassopoulos'], ['J.', '', 'Boletis'], ['A.', '', 'Karafoulidou'], ['I.', '', 'Ketikoglou'], ['D.', '', 'Tsantoulas'], ['I.', '', 'Vafiadi'], ['G.', '', 'Hatzis'], ['A.', '', 'Skoutelis'], ['E.', '', 'Akriviadis'], ['T.', '', 'Vasiliadis'], ['G.', '', 'Kitis'], ['G.', '', 'Magiorkinis'], ['A.', '', 'Hatzakis']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00649.x']
10.1073/pnas.88.8.3392,"Engler, O., Schwendener, R., Dai, W., et. al, A liposomal peptide vaccine inducing CD8 + T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins, Vaccine, 2004",cited-by,10.1016/j.vaccine.2004.05.009,"A liposomal peptide vaccine inducing CD8 + T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins","[['Olivier', 'B.', 'Engler'], ['Reto', 'A.', 'Schwendener'], ['Wen', 'Juan', 'Dai'], ['Benno', '', 'W\xc3\xb6lk'], ['Werner', '', 'Pichler'], ['Darius', '', 'Moradpour'], ['Thomas', '', 'Brunner'], ['Andreas', '', 'Cerny']]",Vaccine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0400413X', u'http://www.imcr.uzh.ch/static/onkwww/vaccine2.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0400413X']"
10.1073/pnas.88.8.3392,"Sherker, A., Twu, J., Reyes, G., et. al, Presence of viral replicative intermediates in the liver and serum of patients infected with hepatitis C virus, Journal of Medical Virology, 1993",cited-by,10.1002/jmv.1890390203,Presence of viral replicative intermediates in the liver and serum of patients infected with hepatitis C virus,"[['Averell', 'H.', 'Sherker'], ['Jr-Shin', '', 'Twu'], ['Gregory', 'R.', 'Reyes'], ['William', 'S.', 'Robinson']]",Journal of Medical Virology,1993,[u'http://doi.wiley.com/10.1002/jmv.1890390203']
10.1073/pnas.88.8.3392,"Howe, A., Cheng, H., Johann, S., et. al, Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV796, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.00238-08,"Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV796","[['Anita', 'Y. M.', 'Howe'], ['Huiming', '', 'Cheng'], ['Stephen', '', 'Johann'], ['Stanley', '', 'Mullen'], ['Srinivas', 'K.', 'Chunduru'], ['Dorothy', 'C.', 'Young'], ['Joel', '', 'Bard'], ['Rajiv', '', 'Chopra'], ['Girija', '', 'Krishnamurthy'], ['Tarek', '', 'Mansour'], ['John', '', ""O'Connell""]]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/9/3327.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00238-08', u'http://aac.asm.org/cgi/reprint/AAC.00238-08v1.pdf']"
10.1073/pnas.88.8.3392,"Marcellin, P., Martinot-Peignoux, M., Gabriel, F., et. al, Hepatitis C virus genotypes in French blood donors, Journal of Medical Virology, 1995",cited-by,10.1002/jmv.1890450408,Hepatitis C virus genotypes in French blood donors,"[['Patrick', '', 'Marcellin'], ['Mich\xc3\xa8le', '', 'Martinot-Peignoux'], ['Franck', '', 'Gabriel'], ['Serge', '', 'Erlinger'], ['Jean-Pierre', '', 'Benhamou'], ['Claude', '', 'Degott'], ['Fran\xc3\xa7oise', '', 'Courtois'], ['Michel', '', 'Branger'], ['Anne', 'Marie', 'Wild']]",Journal of Medical Virology,1995,[u'http://doi.wiley.com/10.1002/jmv.1890450408']
10.1073/pnas.88.8.3392,"Tanaka, Y., Enomoto, N., Kojima, S., et. al, Detection of hepatitis C virus RNA in the liver by in situ hybridization, Liver, 2008",cited-by,10.1111/j.1600-0676.1993.tb00631.x,Detection of hepatitis C virus RNA in the liver by in situ hybridization,"[['Yujiro', '', 'Tanaka'], ['Nobuyuki', '', 'Enomoto'], ['Shigeru', '', 'Kojima'], ['Liang', '', 'Tang'], ['Mieko', '', 'Goto'], ['Fumiaki', '', 'Marumo'], ['Chlfumi', '', 'Sato']]",Liver,2008,[u'http://doi.wiley.com/10.1111/j.1600-0676.1993.tb00631.x']
10.1073/pnas.88.8.3392,"CABOT, B., MARTELL, M., ESTEBAN, J., et. al, Longitudinal Evaluation of the Structure of Replicating and Circulating Hepatitis C Virus Quasispecies in Nonprogressive Chronic Hepatitis C Patients, Journal of Virology, 2001",cited-by,10.1128/JVI.75.24.12005-12013.2001,Longitudinal Evaluation of the Structure of Replicating and Circulating Hepatitis C Virus Quasispecies in Nonprogressive Chronic Hepatitis C Patients,"[['BEATRIZ', '', 'CABOT'], ['MARIA', '', 'MARTELL'], ['JUAN', 'I.', 'ESTEBAN'], ['MARIA', '', 'PIRON'], ['TERESA', '', 'OTERO'], ['RAFAEL', '', 'ESTEBAN'], ['JAIME', '', 'GUARDIA'], ['JORDI', '', 'GOMEZ']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/24/12005.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.24.12005-12013.2001']"
10.1073/pnas.88.8.3392,"Grassi, G., Pozzato, G., Moretti, M., et. al, Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction, Journal of Hepatology, 1995",cited-by,10.1016/0168-8278(95)80198-7,Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction,"[['Gabriele', '', 'Grassi'], ['Gabriele', '', 'Pozzato'], ['Michele', '', 'Moretti'], ['Mauro', '', 'Giacca']]",Journal of Hepatology,1995,"[u'http://www.sciencedirect.com/science/article/pii/0168827895801987', u'http://linkinghub.elsevier.com/retrieve/pii/0168827895801987']"
10.1002~hep.510260130,"Perelson AS, Neumann AU, Markowitz M, Leonard J M, Ho DD. HIV-",references,NOT found in MAS
10.1002~hep.510260130,"Enomoto N, Sato C, Kurosaki M, Marumo F. Hepatitis C virus after 1 dynamics in vivo: virion clearance rate, infected cell lifespan, and viral interferon treatment has the variation in the hypervariable region of generation time. Science 1996;271:1582-1586. envelope 2 gene. J Hepatol 1994;20:252-261.",references,NOT found in MAS
10.1002~hep.510260130,"Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson",references,NOT found in MAS
10.1002~hep.510260130,"Enomoto N, Kurosaki M, Tanaka Y, Marumo F, Sato C. Fluctuation JD, et al. Viral dynamics in human immunodeficiency virus type 1 of hepatitis C virus quasispecies in persistent infection and interferon infection. Nature 1995;373:117-122. treatment revealed by single-strand conformation polymorphism analy-",references,NOT found in MAS
10.1002~hep.510260130,"Zeuzem S, Schmidt J M, Lee J H, Ruster B, Roth WK. Effect of interferon- sis. J Gen Virol 1994;75:1361-1369. alpha on the dynamics of hepatitis C virus turnover in vivo. HEPATOLOGY",references,10.1053/jhep.1996.v23.pm0008591865,Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo,"[[u'S', u'', u'Zeuzem'], [u'JM', u'', u'Schmidt'], [u'J', u'', u'Lee'], [u'B', u'', u'Ruster'], [u'WK', u'', u'Roth']]",Hepatology,1996,"[u'http://www.sciencedirect.com/science/article/pii/S0270913996000584', u'http://linkinghub.elsevier.com/retrieve/pii/S0270913996000584']",./output/10.1002~hep.510260130/10.1053~jhep.1996.v23.pm0008591865
10.1053/jhep.1996.v23.pm0008591865,"Davis, G., Wong, J., McHutchison, J., et. al, Early Virologic Response to Treatment With Peginterferon Alfa-2b plus Ribavirin in Patients With Chronic Hepatitis C, , 2003",cited-by,5370493Early Virologic Response to Treatment With Peginterferon Alfa-2b plus Ribavirin in Patients With Chronic Hepatitis C,Early Virologic Response to Treatment With Peginterferon Alfa-2b plus Ribavirin in Patients With Chronic Hepatitis C,"[['Gary', 'L.', 'Davis'], ['John', 'B.', 'Wong'], ['John', 'G.', 'McHutchison'], ['Michael', 'P.', 'Manns'], ['Joann', '', 'Harvey'], ['Janice', '', 'Albrecht']]",,2003,"[u'http://hepatitis-central.com/hcv/info/2003/sept/hepcinfo645.pdf', u'http://www.hepatitis-central.com/hcv/info/2003/sept/hepcinfo645.pdf']"
10.1053/jhep.1996.v23.pm0008591865,"Ramratnam, B., Bonhoeffer, S., Binley, J., et. al, Rapid production and clearance of HIV1 and hepatitis C virus assessed by large volume plasma apheresis, Lancet, 1999",cited-by,10.1016/S0140-6736(99)02035-8,Rapid production and clearance of HIV1 and hepatitis C virus assessed by large volume plasma apheresis,"[['Bharat', '', 'Ramratnam'], ['Sebastian', '', 'Bonhoeffer'], ['James', '', 'Binley'], ['Arlene', '', 'Hurley'], ['Linqi', '', 'Zhang'], ['John', 'E', 'Mittler'], ['M.', '', 'Markowitz'], ['John', 'P', 'Moore'], ['Alan', 'S', 'Perelson'], ['David', 'D', 'Ho']]",Lancet,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699020358', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699020358']"
10.1053/jhep.1996.v23.pm0008591865,"Zeuzem, S., Herrmann, E., Lee, J., et. al, Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a, Gastroenterology, 2001",cited-by,10.1053/gast.2001.24006,Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a,"[['Stefan', '', 'Zeuzem'], ['Eva', '', 'Herrmann'], ['Jung-Hun', '', 'Lee'], ['Jens', '', 'Fricke'], ['Avidan', 'U.', 'Neumann'], ['Marlene', '', 'Modi'], ['Giuseppe', '', 'Colucci'], ['W.', 'Kurt', 'Roth']]",Gastroenterology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0016508501025355', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508501025355']"
10.1053/jhep.1996.v23.pm0008591865,"Zdilar, D., Franco-Bronson, K., Buchler, N., et. al, Hepatitis C, interferon alfa, and depression, Hepatology, 2000",cited-by,10.1053/jhep.2000.7880,"Hepatitis C, interferon alfa, and depression","[['Darko', '', 'Zdilar'], ['Kathleen', '', 'Franco-Bronson'], ['Nancy', '', 'Buchler'], ['Joseph', 'A.', 'Locala'], ['Zobair', 'M.', 'Younossi']]",Hepatology,2000,"[u'http://www.hcvu.org/mlib/2007_03_15-Zdilar-HCV_and_Depression.pdf', u'http://doi.wiley.com/10.1053/jhep.2000.7880']"
10.1053/jhep.1996.v23.pm0008591865,"Boyer, N., Marcellin, P., , Pathogenesis, diagnosis and management of hepatitis C, Journal of Hepatology, 2000",cited-by,10.1016/S0168-8278(00)80419-5,"Pathogenesis, diagnosis and management of hepatitis C","[['Nathalie', '', 'Boyer'], ['Patrick', '', 'Marcellin']]",Journal of Hepatology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800804195', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800804195']"
10.1053/jhep.1996.v23.pm0008591865,"PAWLOTSKY, J., , Hepatitis C Virus Resistance to Antiviral Therapy, , 2000",cited-by,6316395Hepatitis C Virus Resistance to Antiviral Therapy,Hepatitis C Virus Resistance to Antiviral Therapy,"[['JEAN-MICHEL', '', 'PAWLOTSKY']]",,2000,"[u'http://hepatitis-central.com/hcv/ifn/resistance/hepatitiscentralresistance.pdf', u'http://www.hepatitis-central.com/hcv/ifn/resistance/hepatitiscentralresistance.pdf', u'http://www.heart-intl.net/HEART/Hepatitis/Comp/HCV-resistanttheropy.pdf']"
10.1053/jhep.1996.v23.pm0008591865,"PAWLOTSKY, J., GERMANIDIS, G., NEUMANN, A., et. al, Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations, , 1998",cited-by,6819868Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations,Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations,"[['JEAN-MICHEL', '', 'PAWLOTSKY'], ['GEORGIOS', '', 'GERMANIDIS'], ['AVIDAN', 'U.', 'NEUMANN'], ['MURIEL', '', 'PELLERIN'], ['PIERRE-OLIVIER', '', 'FRAINAIS'], ['DANIEL', '', 'DHUMEAUX']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/4/2795.pdf']
10.1053/jhep.1996.v23.pm0008591865,"Zeuzem, S., Man, R., Honkoop, P., et. al, Dynamics of hepatitis B virus infection in vivo, Journal of Hepatology, 1997",cited-by,10.1016/S0168-8278(97)80345-5,Dynamics of hepatitis B virus infection in vivo,"[['Stefan', '', 'Zeuzem'], ['Robert', 'A. de', 'Man'], ['Pieter', '', 'Honkoop'], ['W.', 'Kurt', 'Roth'], ['Solko', 'W.', 'Schalm'], ['J\xc3\xbcrgen', 'M.', 'Schmidt']]",Journal of Hepatology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0168827897803455', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827897803455']"
10.1053/jhep.1996.v23.pm0008591865,"Castet, V., Fournier, C., Soulier, A., et. al, Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro, Journal of Virology, 2002",cited-by,10.1128/JVI.76.16.8189-8199.2002,Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro,"[['Valerie', '', 'Castet'], ['Chantal', '', 'Fournier'], ['Alexandre', '', 'Soulier'], ['Rozenn', '', 'Brillet'], ['Joliette', '', 'Coste'], ['Dominique', '', 'Larrey'], ['Daniel', '', 'Dhumeaux'], ['Patrick', '', 'Maurel'], ['J.-M.', '', 'Pawlotsky']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/16/8189.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.16.8189-8199.2002']"
10.1053/jhep.1996.v23.pm0008591865,"Bekkering, F., Brouwer, J., Leroux-Roels, G., et. al, Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy, Journal of Hepatology, 1998",cited-by,10.1016/S0168-8278(98)80343-7,Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy,"[['Frank', 'C.', 'Bekkering'], ['Johannes', 'T.', 'Brouwer'], ['Geert', '', 'Leroux-Roels'], ['Hans', 'Van', 'Vlierberghe'], ['Andre', '', 'Elewaut'], ['Solko', 'W.', 'Schalm']]",Journal of Hepatology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0168827898803437', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827898803437']"
10.1053/jhep.1996.v23.pm0008591865,"Kau, A., Vermehren, J., Sarrazin, C., , Treatment predictors of a sustained virologic response in hepatitis B and C, Journal of Hepatology, 2008",cited-by,10.1016/j.jhep.2008.07.013,Treatment predictors of a sustained virologic response in hepatitis B and C,"[['Annika', '', 'Kau'], ['Johannes', '', 'Vermehren'], ['Christoph', '', 'Sarrazin']]",Journal of Hepatology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0168827808004856', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827808004856']"
10.1053/jhep.1996.v23.pm0008591865,"Layden, J., Layden, T., Reddy, K., et. al, First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00377.x,First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline,"[['Jennifer', 'E.', 'Layden'], ['Thomas', 'J.', 'Layden'], ['K.', 'Rajender', 'Reddy'], ['Rachel', 'S', 'Levy-Drummer'], ['Jennifer', '', 'Poulakos'], ['Avidan', 'U.', 'Neumann']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00377.x']
10.1053/jhep.1996.v23.pm0008591865,"Hu, K., Vierling, J., Redeker, A., , Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00253.x,"Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection","[['Ke-Qin', '', 'Hu'], ['John', 'M.', 'Vierling'], ['Allan', 'G.', 'Redeker']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00253.x']
10.1053/jhep.1996.v23.pm0008591865,"McGuinness, P., Davies, S., McCaughan, G., , Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection, Gut, 2000",cited-by,10.1136/gut.46.2.260,"Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection","[['P', 'H', 'McGuinness'], ['S', '', 'Davies'], ['G', 'W', 'McCaughan']]",Gut,2000,"[u'http://gut.bmj.com/cgi/doi/10.1136/gut.46.2.260', u'http://dx.doi.org/']"
10.1053/jhep.1996.v23.pm0008591865,"Sherman, K., Shire, N., Rouster, S., et. al, Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients, Gastroenterology, 2005",cited-by,10.1053/j.gastro.2004.11.059,Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients,"[['Kenneth', 'E.', 'Sherman'], ['Norah', 'J.', 'Shire'], ['Susan', 'D.', 'Rouster'], ['Marion', 'G.', 'Peters'], ['Margaret', 'James', 'Koziel'], ['Raymond', 'T.', 'Chung'], ['Paul', 'S.', 'Horn']]",Gastroenterology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0016508504021638', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508504021638']"
10.1053/jhep.1996.v23.pm0008591865,", K., , Z., , V., et. al, Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha, European Journal of Clinical Investigation, 2000",cited-by,10.1046/j.1365-2362.2000.00608.x,Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha,"[['Konrad', '', ''], ['Zeuzem', '', ''], ['Vicini', '', ''], ['Toffolo', '', ''], ['Briem', '', ''], ['Lormann', '', ''], ['Herrmann', '', ''], ['Kusterer', '', ''], ['Teuber', '', ''], ['Cobelli', '', ''], ['Usadel', '', '']]",European Journal of Clinical Investigation,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2362.2000.00608.x']
10.1053/jhep.1996.v23.pm0008591865,"Lee, J., Wagner, M., Roth, W., et. al, Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus, Journal of Hepatology, 1998",cited-by,10.1016/S0168-8278(98)80175-X,Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus,"[['Jung-Hun', '', 'Lee'], ['Michael', 'von', 'Wagner'], ['Willi', 'Kurt', 'Roth'], ['Gerlinde', '', 'Teuber'], ['Christoph', '', 'Sarrazin'], ['Stefan', '', 'Zeuzem']]",Journal of Hepatology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S016882789880175X', u'http://linkinghub.elsevier.com/retrieve/pii/S016882789880175X']"
10.1053/jhep.1996.v23.pm0008591865,"Hodinka, R., , The clinical utility of viral quantitation using molecular methods, Clinical and Diagnostic Virology, 1998",cited-by,10.1016/S0928-0197(98)00016-6,The clinical utility of viral quantitation using molecular methods,"[['Richard', 'L', 'Hodinka']]",Clinical and Diagnostic Virology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0928019798000166', u'http://linkinghub.elsevier.com/retrieve/pii/S0928019798000166']"
10.1053/jhep.1996.v23.pm0008591865,"Dahari, H., Major, M., Zhang, X., et. al, Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production, Gastroenterology, 2005",cited-by,10.1053/j.gastro.2005.01.049,Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production,"[['Harel', '', 'Dahari'], ['Marian', '', 'Major'], ['Xinan', '', 'Zhang'], ['Kathleen', '', 'Mihalik'], ['Charles', 'M.', 'Rice'], ['Alan', 'S.', 'Perelson'], ['Stephen', 'M.', 'Feinstone'], ['Avidan', 'U.', 'Neumann']]",Gastroenterology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0016508505001617', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508505001617']"
10.1053/jhep.1996.v23.pm0008591865,"Charlton, M., , Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence, Liver Transplantation, 2003",cited-by,10.1053/jlts.2003.50245,"Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence","[['Michael', '', 'Charlton']]",Liver Transplantation,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1527646503810274', u'http://doi.wiley.com/10.1053/jlts.2003.50245']"
10.1053/jhep.1996.v23.pm0008591865,"TONIUTTO, P., FABRIS, C., FUMO, E., et. al, Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy, Journal of Gastroenterology and Hepatology, 2005",cited-by,10.1111/j.1440-1746.2005.03795.x,Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy,"[['PIERLUIGI', '', 'TONIUTTO'], ['CARLO', '', 'FABRIS'], ['ELISABETTA', '', 'FUMO'], ['LUCA', '', 'APOLLONIO'], ['MAYA', '', 'CALDATO'], ['CLAUDIO', '', 'AVELLINI'], ['ROSALBA', '', 'MINISINI'], ['MARIO', '', 'PIRISI']]",Journal of Gastroenterology and Hepatology,2005,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1440-1746.2005.03795.x']
10.1053/jhep.1996.v23.pm0008591865,"Konrad, T., Zeuzem, S., Toffolo, G., et. al, Severity of HCV-Induced Liver Damage Alters Glucose Homeostasis in Noncirrhotic Patients with Chronic HCV Infection, Digestion, 2000",cited-by,10.1159/000007778,Severity of HCV-Induced Liver Damage Alters Glucose Homeostasis in Noncirrhotic Patients with Chronic HCV Infection,"[['T.', '', 'Konrad'], ['S.', '', 'Zeuzem'], ['G.', '', 'Toffolo'], ['P.', '', 'Vicini'], ['G.', '', 'Teuber'], ['D.', '', 'Briem'], ['J.', '', 'Lormann'], ['T.', '', 'Lenz'], ['G.', '', 'Herrmann'], ['A.', '', 'Berger'], ['C.', '', 'Cobelli'], ['K.-H.', '', 'Usadel']]",Digestion,2000,"[u'http://www.online.karger.com/doi/10.1159/000007778', u'http://www.karger.com/doi/10.1159/000007778']"
10.1053/jhep.1996.v23.pm0008591865,"Nevens, F., Bekkering, F., Bourgeois, N., et. al, Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients, Journal of Hepatology, 2004",cited-by,10.1016/j.jhep.2003.12.017,Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients,"[['Frederik', '', 'Nevens'], ['Frank', 'C', 'Bekkering'], ['Nadine', '', 'Bourgeois'], ['Hans', 'Van', 'Vlierberghe'], ['Christine', 'J', 'Weegink'], ['V\xc3\xa9ronique', '', 'Lefebvre'], ['Jan', 'van', 'Hattum'], ['Jean', '', 'Henrion'], ['Jean', '', 'Delwaide']]",Journal of Hepatology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S016882780400011X', u'http://linkinghub.elsevier.com/retrieve/pii/S016882780400011X']"
10.1053/jhep.1996.v23.pm0008591865,"Akuta, N., Suzuki, F., Kawamura, Y., et. al, Prediction of Response to Pegylated Interferon and Ribavirin in Hepatitis C by Polymorphisms in the Viral Core Protein and Very Early Dynamics of Viremia, Intervirology, 2007",cited-by,10.1159/000107707,Prediction of Response to Pegylated Interferon and Ribavirin in Hepatitis C by Polymorphisms in the Viral Core Protein and Very Early Dynamics of Viremia,"[['Norio', '', 'Akuta'], ['Fumitaka', '', 'Suzuki'], ['Yusuke', '', 'Kawamura'], ['Hiromi', '', 'Yatsuji'], ['Hitomi', '', 'Sezaki'], ['Yoshiyuki', '', 'Suzuki'], ['Tetsuya', '', 'Hosaka'], ['Masahiro', '', 'Kobayashi'], ['Mariko', '', 'Kobayashi'], ['Yasuji', '', 'Arase'], ['Kenji', '', 'Ikeda'], ['Yuzo', '', 'Miyakawa'], ['Hiromitsu', '', 'Kumada']]",Intervirology,2007,"[u'http://www.karger.com/doi/10.1159/000107707', u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000107707']"
10.1053/jhep.1996.v23.pm0008591865,"Carlsson, T., Reichard, O., Norkrans, G., et. al, Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response, Journal of Viral Hepatitis, 2005",cited-by,10.1111/j.1365-2893.2005.00621.x,Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response,"[['T.', '', 'Carlsson'], ['O.', '', 'Reichard'], ['G.', '', 'Norkrans'], ['J.', '', 'Blackberg'], ['P.', '', 'Sangfelt'], ['E.', '', 'Wallmark'], ['O.', '', 'Weiland']]",Journal of Viral Hepatitis,2005,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00621.x']
10.1053/jhep.1996.v23.pm0008591865,"LASKUS, T., WANG, L., RADKOWSKI, M., et. al, Exposure of Hepatitis C Virus (HCV) RNA-Positive Recipients to HCV RNA-Positive Blood Donors Results in Rapid Predominance of a Single Donor Strain and Exclusion and/or Suppression of the Recipient Strain, Journal of Virology, 2001",cited-by,10.1128/JVI.75.5.2059-2066.2001,Exposure of Hepatitis C Virus (HCV) RNA-Positive Recipients to HCV RNA-Positive Blood Donors Results in Rapid Predominance of a Single Donor Strain and Exclusion and/or Suppression of the Recipient Strain,"[['TOMASZ', '', 'LASKUS'], ['LIAN-FU', '', 'WANG'], ['MAREK', '', 'RADKOWSKI'], ['HUGO', '', 'VARGAS'], ['MAREK', '', 'NOWICKI'], ['JEFFREY', '', 'WILKINSON'], ['JORGE', '', 'RAKELA']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/5/2059.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.5.2059-2066.2001']"
10.1053/jhep.1996.v23.pm0008591865,"Zeuzem, S., , Clinical implications of hepatitis C viral kinetics, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80376-6,Clinical implications of hepatitis C viral kinetics,"[['Stefan', '', 'Zeuzem']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803766', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803766']"
10.1053/jhep.1996.v23.pm0008591865,"Kew, M., Francois, G., Lavanchy, D., et. al, Prevention of hepatitis C virus infection, Journal of Viral Hepatitis, 2004",cited-by,10.1111/j.1365-2893.2004.00492.x,Prevention of hepatitis C virus infection,"[['M.', '', 'Kew'], ['G.', '', 'Francois'], ['D.', '', 'Lavanchy'], ['H.', '', 'Margolis'], ['P.', 'Van', 'Damme'], ['P.', '', 'Grob'], ['J.', '', 'Hallauer'], ['D.', '', 'Shouval'], ['G.', '', 'Leroux-Roels'], ['A.', '', 'Meheus']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2004.00492.x']
10.1053/jhep.1996.v23.pm0008591865,"Shiratori, Y., Perelson, A., Weinberger, L., et. al, Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta, Journal of Hepatology, 2000",cited-by,10.1016/S0168-8278(00)80373-6,Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta,"[['Yasushi', '', 'Shiratori'], ['Alan', 'S.', 'Perelson'], ['Leor', '', 'Weinberger'], ['Fumio', '', 'Imazeki'], ['Osamu', '', 'Yokosuka'], ['Ryo', '', 'Nakata'], ['Masashi', '', 'Ihori'], ['Katsutaro', '', 'Hirota'], ['Naomi', '', 'Ono'], ['Hisamoto', '', 'Kuroda'], ['Teiji', '', 'Motojima'], ['Masaru', '', 'Nishigaki'], ['Masao', '', 'Omata']]",Journal of Hepatology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800803736', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800803736']"
10.1053/jhep.1996.v23.pm0008591865,"Takahashi, M., Saito, H., Higashimoto, M., et. al, Benefit of Hepatitis C Virus Core Antigen Assay in Prediction of Therapeutic Response to Interferon and Ribavirin Combination Therapy, , 2005",cited-by,6752224Benefit of Hepatitis C Virus Core Antigen Assay in Prediction of Therapeutic Response to Interferon and Ribavirin Combination Therapy,Benefit of Hepatitis C Virus Core Antigen Assay in Prediction of Therapeutic Response to Interferon and Ribavirin Combination Therapy,"[['Masahiko', '', 'Takahashi'], ['Hidetsugu', '', 'Saito'], ['Makiko', '', 'Higashimoto'], ['Kazuhiro', '', 'Atsukawa'], ['Hiromasa', '', 'Ishii']]",,2005,[u'http://jcm.asm.org/cgi/reprint/43/1/186.pdf']
10.1053/jhep.1996.v23.pm0008591865,"Puoti, C., Stati, T., Magrini, A., , Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels, Liver International, 1999",cited-by,10.1111/j.1478-3231.1999.tb00018.x,Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels,"[['Claudio', '', 'Puoti'], ['Tonino', '', 'Stati'], ['Andrea', '', 'Magrini']]",Liver International,1999,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1478-3231.1999.tb00018.x']
10.1053/jhep.1996.v23.pm0008591865,"Ribeiro, R., Layden-almer, J., Powers, K., et. al, Dynamics of Alanine Aminotransferase During Hepatitis C Virus Treatment, , 0",cited-by,5313224Dynamics of Alanine Aminotransferase During Hepatitis C Virus Treatment,Dynamics of Alanine Aminotransferase During Hepatitis C Virus Treatment,"[['Ruy', 'M.', 'Ribeiro'], ['Jennifer', '', 'Layden-almer'], ['Kimberly', 'A.', 'Powers'], ['Thomas', 'J.', 'Layden'], ['Alan', 'S.', 'Perelson']]",,0,[u'http://hepatitis-central.com/hcv/info/2003/aug/hepcinfo509.pdf']
10.1053/jhep.1996.v23.pm0008591865,"ASAHINA, Y., IZUMI, N., UCHIHARA, M., et. al, A Potent Antiviral Effect on Hepatitis C Viral Dynamics in Serum and Peripheral Blood Mononuclear Cells During Combination Therapy With High-Dose Daily Interferon Alfa Plus Ribavirin and Intravenous Twice-Daily Treatment With Interferon Beta, , 0",cited-by,12344390A Potent Antiviral Effect on Hepatitis C Viral Dynamics in Serum and Peripheral Blood Mononuclear Cells During Combination Therapy With High-Dose Daily Interferon Alfa Plus Ribavirin and Intravenous Twice-Daily Treatment With Interferon Beta,A Potent Antiviral Effect on Hepatitis C Viral Dynamics in Serum and Peripheral Blood Mononuclear Cells During Combination Therapy With High-Dose Daily Interferon Alfa Plus Ribavirin and Intravenous Twice-Daily Treatment With Interferon Beta,"[['YASUHIRO', '', 'ASAHINA'], ['N', 'AMIKI', 'IZUMI'], ['M', 'ASAKATSU', 'UCHIHARA'], ['O', 'SAMU', 'NOGUCHI'], ['K', 'AORU', 'TSUCHIYA'], ['K', 'OSEI', 'HAMANO'], ['NOBUHIKO', '', 'KANAZAWA'], ['J', 'UN', 'ITAKURA'], ['S', 'HOZO', 'MIYAKE'], ['TAKAHIRO', '', 'SAKAI']]",,0,[u'http://www.infeksiyon.org/docs/pdf/literaturden_secmeler/A%20Potent%20Antiviral%20Effect%20on%20Hepatitis%20C%20Viral%20Dynamics%20by%20High-Dose%20Daily%20Interferon%20Alfa%20Plus%20Ribavirin.pdf']
10.1053/jhep.1996.v23.pm0008591865,"Yu, M., Chuang, W., Dai, C., et. al, Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy, Translational Research, 2006",cited-by,10.1016/j.trsl.2006.04.006,Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy,"[['Ming-Lung', '', 'Yu'], ['Wan-Long', '', 'Chuang'], ['Chia-Yen', '', 'Dai'], ['Li-Po', '', 'Lee'], ['Ming-Yen', '', 'Hsieh'], ['Zu-Yau', '', 'Lin'], ['Shinn-Cherng', '', 'Chen'], ['Ming-Yuh', '', 'Hsieh'], ['Liang-Yen', '', 'Wang'], ['Wen-Yu', '', 'Chang'], ['Sun-Lung', '', 'Tsai'], ['Hsing-Tao', '', 'Kuo']]",Translational Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1931524406003094', u'http://linkinghub.elsevier.com/retrieve/pii/S1931524406003094']"
10.1053/jhep.1996.v23.pm0008591865,"Cotler, S., Layden, J., Neumann, A., et. al, First phase hepatitis c viral kinetics in previous nonresponders patients, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00401.x,First phase hepatitis c viral kinetics in previous nonresponders patients,"[['S.', 'J.', 'Cotler'], ['J.', 'E.', 'Layden'], ['A.', 'U.', 'Neumann'], ['D.', 'M.', 'Jensen']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00401.x']
10.1053/jhep.1996.v23.pm0008591865,"Fukutomi, T., Nakamuta, M., Fukutomi, M., et. al, Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(00)00044-1,Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy,"[['Takayoshi', '', 'Fukutomi'], ['Makoto', '', 'Nakamuta'], ['Marie', '', 'Fukutomi'], ['Masataka', '', 'Iwao'], ['Hironobu', '', 'Watanabe'], ['Kaichiro', '', 'Hiroshige'], ['Yuichi', '', 'Tanabe'], ['Hajime', '', 'Nawata']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800000441', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800000441']"
10.1053/jhep.1996.v23.pm0008591865,"MIHM, U., HERRMANN, E., SARRAZIN, C., et. al, Review article: predicting response in hepatitis C virus therapy, Alimentary Pharmacology & Therapeutics, 2006",cited-by,10.1111/j.1365-2036.2006.02863.x,Review article: predicting response in hepatitis C virus therapy,"[['U.', '', 'MIHM'], ['E.', '', 'HERRMANN'], ['C.', '', 'SARRAZIN'], ['S.', '', 'ZEUZEM']]",Alimentary Pharmacology & Therapeutics,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2036.2006.02863.x']
10.1053/jhep.1996.v23.pm0008591865,"Kronenberger, B., Wagner, M., Herrmann, E., et. al, Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C, Journal of Viral Hepatitis, 2005",cited-by,10.1111/j.1365-2893.2005.00594.x,Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C,"[['B.', '', 'Kronenberger'], ['M.', '', 'Wagner'], ['E.', '', 'Herrmann'], ['U.', '', 'Mihm'], ['A.', '', 'Piiper'], ['C.', '', 'Sarrazin'], ['S.', '', 'Zeuzem']]",Journal of Viral Hepatitis,2005,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2005.00594.x']
10.1053/jhep.1996.v23.pm0008591865,"Mangia, A., Villani, M., Minerva, N., et. al, Efficacy of 5 MU of interferon in combination with ribavirin for naı̈ve patients with chronic hepatitis C virus: a randomized controlled trial, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(00)00024-6,Efficacy of 5 MU of interferon in combination with ribavirin for naı̈ve patients with chronic hepatitis C virus: a randomized controlled trial,"[['Alessandra', '', 'Mangia'], ['Maria', 'Rosaria', 'Villani'], ['Nicola', '', 'Minerva'], ['Gioacchino', '', 'Leandro'], ['Donato', '', 'Bacca'], ['Marina', '', 'Cela'], ['Vito', '', 'Carretta'], ['Vito', '', 'Attino'], ['Francesco', '', 'Ventrella'], ['Antonio', '', 'Giangaspero'], ['Angelo', '', 'Andriulli']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800000246', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800000246']"
10.1053/jhep.1996.v23.pm0008591865,"Asahina, Y., Izumi, N., Uchihara, M., et. al, Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimens, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00287-3,Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimens,"[['Yasuhiro', '', 'Asahina'], ['Namiki', '', 'Izumi'], ['Masakatsu', '', 'Uchihara'], ['Osamu', '', 'Noguchi'], ['Yuki', '', 'Nishimura'], ['Kazunari', '', 'Inoue'], ['Ken', '', 'Ueda'], ['Kaoru', '', 'Tsuchiya'], ['Kosei', '', 'Hamano'], ['Jun', '', 'Itakura'], ['Shozo', '', 'Miyake']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803002873', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803002873']"
10.1053/jhep.1996.v23.pm0008591865,"Moreno-Otero, R., , Therapeutic modalities in hepatitis C: challenges and development, Journal of Viral Hepatitis, 2005",cited-by,10.1111/j.1365-2893.2005.00563.x,Therapeutic modalities in hepatitis C: challenges and development,"[['R.', '', 'Moreno-Otero']]",Journal of Viral Hepatitis,2005,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2005.00563.x']
10.1053/jhep.1996.v23.pm0008591865,"BEKKERING, F., STALGIS, C., MCHUTCHISON, J., et. al, Estimation of Early Hepatitis C Viral Clearance in Patients Receiving Daily Interferon and Ribavirin Therapy Using a Mathematical Model, , 0",cited-by,5353877Estimation of Early Hepatitis C Viral Clearance in Patients Receiving Daily Interferon and Ribavirin Therapy Using a Mathematical Model,Estimation of Early Hepatitis C Viral Clearance in Patients Receiving Daily Interferon and Ribavirin Therapy Using a Mathematical Model,"[['FRANK', 'C.', 'BEKKERING'], ['CARLOS', '', 'STALGIS'], ['JOHN', 'G.', 'MCHUTCHISON'], ['JOHANNES', 'T.', 'BROUWER'], ['ALAN', 'S.', 'PERELSON']]",,0,[u'http://www.infeksiyon.org/docs/pdf/literaturden_secmeler/estimation%20of%20early%20hepatitis%20c%20viral%20clearance%20in%20patients%20receiving%20daily%20interferon%20and%20ribavirin%20therapy%20using%20a%20mathematical%20model.pdf']
10.1053/jhep.1996.v23.pm0008591865,"Wagner, M., Lee, J., Ruster, B., et. al, Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00457.x,Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment,"[['M.', '', 'Wagner'], ['J.-H.', '', 'Lee'], ['B.', '', 'Ruster'], ['B.', '', 'Kronenberger'], ['C.', '', 'Sarrazin'], ['W.', 'K.', 'Roth'], ['S.', '', 'Zeuzem']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00457.x']
10.1053/jhep.1996.v23.pm0008591865,"Welker, M., Zeuzem, S., , Occult hepatitis C: How convincing are the current data?, Hepatology, 2009",cited-by,10.1002/hep.22706,Occult hepatitis C: How convincing are the current data?,"[['Martin-Walter', '', 'Welker'], ['Stefan', '', 'Zeuzem']]",Hepatology,2009,[u'http://doi.wiley.com/10.1002/hep.22706']
10.1053/jhep.1996.v23.pm0008591865,"Jessner, W., Watkins-Riedel, T., Formann, E., et. al, Hepatitis C viral dynamics: basic concept and clinical significance, Journal of Clinical Virology, 2002",cited-by,10.1016/S1386-6532(02)00194-4,Hepatitis C viral dynamics: basic concept and clinical significance,"[['Wolfgang', '', 'Jessner'], ['Thomas', '', 'Watkins-Riedel'], ['Elisabeth', '', 'Formann'], ['Petra', '', 'Steindl-Munda'], ['Peter', '', 'Ferenci']]",Journal of Clinical Virology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1386653202001944', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653202001944']"
10.1053/jhep.1996.v23.pm0008591865,"Hadziyannis, A., Papaioannou, C., Spanou, F., et. al, Induction interferon therapy in naive patients with chronic hepatitis C: increased end-of-treatment virological responses but absence of long-term benefit, Alimentary Pharmacology & Therapeutics, 2001",cited-by,10.1046/j.1365-2036.2001.00946.x,Induction interferon therapy in naive patients with chronic hepatitis C: increased end-of-treatment virological responses but absence of long-term benefit,"[['A.', 'S.', 'Hadziyannis'], ['C.', '', 'Papaioannou'], ['F.', '', 'Spanou'], ['E.', 'K.', 'Manesis'], ['S.', 'J.', 'Hadziyannis']]",Alimentary Pharmacology & Therapeutics,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2001.00946.x']
10.1053/jhep.1996.v23.pm0008591865,"Cotler, S., Reddy, K., McCone, J., et. al, An Analysis of Acute Changes in Interleukin6 Levels After Treatment of Hepatitis C with Consensus Interferon, Journal of Interferon and Cytokine Research, 2001",cited-by,10.1089/107999001317205132,An Analysis of Acute Changes in Interleukin6 Levels After Treatment of Hepatitis C with Consensus Interferon,"[['Scott', 'J.', 'Cotler'], ['K.', 'Rajender', 'Reddy'], ['Jon', '', 'McCone'], ['Darin', 'L.', 'Wolfe'], ['Anguo', '', 'Liu'], ['Teresa', 'R.', 'Craft'], ['Mary', 'W.', 'Ferris'], ['Andrew', 'J.', 'Conrad'], ['Jeff', '', 'Albrecht'], ['Mary', '', 'Morrissey'], ['Daniel', 'R.', 'Ganger'], ['Howard', '', 'Rosenblate'], ['Lawrence', 'M.', 'Blatt'], ['Donald', 'M.', 'Jensen'], ['Milton', 'W.', 'Taylor']]",Journal of Interferon and Cytokine Research,2001,[u'http://www.liebertonline.com/doi/abs/10.1089%2F107999001317205132']
10.1053/jhep.1996.v23.pm0008591865,"Kronenberger, B., Herrmann, E., Hofmann, W., et. al, Dynamics of CD81 expression on lymphocyte subsets during interferon- -based antiviral treatment of patients with chronic hepatitis C, Journal of Leukocyte Biology, 2006",cited-by,10.1189/jlb.0106047,Dynamics of CD81 expression on lymphocyte subsets during interferon- -based antiviral treatment of patients with chronic hepatitis C,"[['Bernd', '', 'Kronenberger'], ['Eva', '', 'Herrmann'], ['W.', 'Peter', 'Hofmann'], ['Heiner', '', 'Wedemeyer'], ['Martina', '', 'Sester'], ['Ulrike', '', 'Mihm'], ['Temam', '', 'Ghaliai'], ['Stefan', '', 'Zeuzem'], ['Christoph', '', 'Sarrazin']]",Journal of Leukocyte Biology,2006,"[u'http://www.jleukbio.org/cgi/reprint/80/2/298.pdf', u'http://www.jleukbio.org/cgi/doi/10.1189/jlb.0106047']"
10.1053/jhep.1996.v23.pm0008591865,"Engler, S., Flechtenmacher, C., Wiedemann, K., et. al, Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection, Journal of Viral Hepatitis, 2004",cited-by,10.1046/j.1352-0504.2003.00463.x,Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection,"[['S.', '', 'Engler'], ['C.', '', 'Flechtenmacher'], ['K.', 'H.', 'Wiedemann'], ['R.', '', 'Gugler'], ['W.', '', 'Stremmel'], ['B.', '', 'Kallinowski']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1352-0504.2003.00463.x']
10.1053/jhep.1996.v23.pm0008591865,"Lédinghen, V., Trimoulet, P., Winnock, M., et. al, Daily or three times per week interferon α-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00071-5,Daily or three times per week interferon α-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone,"[['Victor', 'de', 'L\xc3\xa9dinghen'], ['Pascale', '', 'Trimoulet'], ['Maria', '', 'Winnock'], ['Pierre-Henri', '', 'Bernard'], ['Marc', '', 'Bourli\xc3\xa8re'], ['Isabelle', '', 'Portal'], ['Andr\xc3\xa9-Jean', '', 'R\xc3\xa9my'], ['Nathalie', '', 'Szostak'], ['St\xc3\xa9phane', '', 'L\xc3\xa9vy'], ['Albert', '', 'Tran'], ['Armand', '', 'Abergel'], ['Genevi\xc3\xa8ve', '', 'Ch\xc3\xaane'], ['Herv\xc3\xa9', '', 'Fleury'], ['Patrice', '', 'Couzigou']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802000715', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802000715']"
10.1053/jhep.1996.v23.pm0008591865,"Shiratori, Y., Omata, M., , Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: how does this modify the treatment course?, Journal of Gastroenterology and Hepatology, 2000",cited-by,10.1046/j.1440-1746.2000.02116.x,Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: how does this modify the treatment course?,"[['Yasushi', '', 'Shiratori'], ['Masao', '', 'Omata']]",Journal of Gastroenterology and Hepatology,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2000.02116.x']
10.1053/jhep.1996.v23.pm0008591865,"Scheuer, P., Krawczynski, K., Dhillon, A., , Histopathology and detection of hepatitis C virus in liver, Springer Seminars in Immunopathology, 1997",cited-by,10.1007/BF00945023,Histopathology and detection of hepatitis C virus in liver,"[['Peter', 'J', 'Scheuer'], ['Kris', '', 'Krawczynski'], ['Amar', 'P', 'Dhillon']]",Springer Seminars in Immunopathology,1997,"[u'http://www.springerlink.com/index/j3x8722147647634.pdf', u'http://www.springerlink.com/content/j3x8722147647634', u'http://www.springerlink.com/index/10.1007/BF00945023', u'http://www.springerlink.com/index/pdf/10.1007/BF00945023']"
10.1053/jhep.1996.v23.pm0008591865,"Lindh, M., Alestig, E., Arnholm, B., et. al, Response Prediction and Treatment Tailoring for Chronic Hepatitis C Virus Genotype 1 Infection, , 2007",cited-by,6885981Response Prediction and Treatment Tailoring for Chronic Hepatitis C Virus Genotype 1 Infection,Response Prediction and Treatment Tailoring for Chronic Hepatitis C Virus Genotype 1 Infection,"[['Magnus', '', 'Lindh'], ['Erik', '', 'Alestig'], ['Birgitta', '', 'Arnholm'], ['Anders', '', 'Eilard'], ['Kristoffer', '', 'Hellstrand'], ['Martin', '', 'Lagging'], ['Thomas', '', 'Wahlberg'], ['Rune', '', 'Wejst\xc3\xa5l'], ['Johan', '', 'Westin'], ['Gunnar', '', 'Norkrans']]",,2007,[u'http://jcm.asm.org/cgi/reprint/45/8/2439.pdf']
10.1053/jhep.1996.v23.pm0008591865,"Nagaki, M., Imose, M., Naiki, T., et. al, Prospective study on early virologic response to treatment with interferon α-2b plus ribavirin in patients with chronic hepatitis C genotype 1b, Hepatology Research, 2005",cited-by,10.1016/j.hepres.2005.08.010,Prospective study on early virologic response to treatment with interferon α-2b plus ribavirin in patients with chronic hepatitis C genotype 1b,"[['Masahito', '', 'Nagaki'], ['Motoaki', '', 'Imose'], ['Takafumi', '', 'Naiki'], ['Kiminori', '', 'Kimura'], ['Hideki', '', 'Hayashi'], ['Masaru', '', 'Shimizu'], ['Hiroo', '', 'Ohnishi'], ['Eiichi', '', 'Tomita'], ['Jun\xe2\x80\x99ichi', '', 'Sugihara'], ['Kazuo', '', 'Amano'], ['Tsutomu', '', 'Sakai'], ['Takao', '', 'Kojima'], ['Naoki', '', 'Katsumura'], ['Yoshimasa', '', 'Kondo'], ['Masao', '', 'Fujimoto'], ['Hisataka', '', 'Moriwaki']]",Hepatology Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1386634605003281', u'http://linkinghub.elsevier.com/retrieve/pii/S1386634605003281']"
10.1053/jhep.1996.v23.pm0008591865,"Izumi, N., Asahina, Y., Kurosaki, M., et. al, A Comparison of the Exponential Decay Slope between PEG-IFN alfa-2b/Ribavirin and IFN alfa-2b/Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Genotype 1b Infection and a High Viral Load, Intervirology, 2004",cited-by,10.1159/000077833,A Comparison of the Exponential Decay Slope between PEG-IFN alfa-2b/Ribavirin and IFN alfa-2b/Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Genotype 1b Infection and a High Viral Load,"[['Namiki', '', 'Izumi'], ['Yasuhiro', '', 'Asahina'], ['Masayuki', '', 'Kurosaki'], ['Masakatsu', '', 'Uchihara'], ['Yuki', '', 'Nishimura'], ['Kazunari', '', 'Inoue'], ['Ken', '', 'Ueda'], ['Kaoru', '', 'Tsuchiya'], ['Kousei', '', 'Hamano'], ['Jun', '', 'Itakura'], ['Shozo', '', 'Miyake']]",Intervirology,2004,"[u'http://www.karger.com/doi/10.1159/000077833', u'http://www.online.karger.com/doi/10.1159/000077833']"
10.1053/jhep.1996.v23.pm0008591865,"Perez, R., Jimenez, M., Crespo, J., et. al, Comparative study of the efficacy of an induction dose of interferon-alpha2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00461.x,Comparative study of the efficacy of an induction dose of interferon-alpha2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C,"[['R.', '', 'Perez'], ['M.', '', 'Jimenez'], ['J.', '', 'Crespo'], ['M.', '', 'Diago'], ['J.', '', 'Enriquez'], ['P.', '', 'Vaquero'], ['R.', '', 'Sola'], ['J.', 'L.', 'Olcoz'], ['M.', '', 'Romero'], ['J.', '', 'Salmeron'], ['Ma', 'I.', 'Blanco'], ['Ma', '', 'Ona'], ['S.', '', 'Melon'], ['L.', '', 'Rodrigo']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00461.x']
10.1053/jhep.1996.v23.pm0008591865,"Vlierberghe, H., Leroux-Roels, G., Adler, M., et. al, Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00466.x,Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial,"[['H.', 'Van', 'Vlierberghe'], ['G.', '', 'Leroux-Roels'], ['M.', '', 'Adler'], ['N.', '', 'Bourgeois'], ['F.', '', 'Nevens'], ['Y.', '', 'Horsmans'], ['J.', '', 'Brouwer'], ['I.', '', 'Colle'], ['J.', '', 'Delwaide'], ['R.', '', 'Brenard'], ['B.', '', 'Bastens'], ['J.', '', 'Henrion'], ['R.', 'A.', 'Vries'], ['C.', '', 'Galocsy'], ['P.', '', 'Michielsen'], ['G.', '', 'Robaeys'], ['L.', '', 'Bruckers']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00466.x']
10.1053/jhep.1996.v23.pm0008591865,"Arends, J., Stuart, J., Baak, L., et. al, Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy, Journal of Viral Hepatitis, 2009",cited-by,10.1111/j.1365-2893.2009.01143.x,Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy,"[['J.', 'E.', 'Arends'], ['J.', 'W. T. Cohen', 'Stuart'], ['L.', 'C.', 'Baak'], ['M.', 'E. van der', 'Ende'], ['K.', 'J. van', 'Erpecum'], ['C.', 'P. M.', 'Simons'], ['G.', 'J.', 'Boland'], ['D.', 'van', 'Baarle'], ['A.', 'I. M.', 'Hoepelman']]",Journal of Viral Hepatitis,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2009.01143.x']
10.1053/jhep.1996.v23.pm0008591865,"Perelson, A., Ribeiro, R., , Estimating drug efficacy and viral dynamic parameters: HIV and HCV, Statistics in Medicine, 2008",cited-by,10.1002/sim.3116,Estimating drug efficacy and viral dynamic parameters: HIV and HCV,"[['Alan', 'S.', 'Perelson'], ['Ruy', 'M.', 'Ribeiro']]",Statistics in Medicine,2008,[u'http://doi.wiley.com/10.1002/sim.3116']
10.1053/jhep.1996.v23.pm0008591865,"Pugnale, P., Latorre, P., Rossi, C., et. al, Real-time multiplex PCR assay to quantify hepatitis C virus RNA in peripheral blood mononuclear cells, Journal of Virological Methods, 2006",cited-by,10.1016/j.jviromet.2005.11.007,Real-time multiplex PCR assay to quantify hepatitis C virus RNA in peripheral blood mononuclear cells,"[['Paolo', '', 'Pugnale'], ['Patrizia', '', 'Latorre'], ['Christine', '', 'Rossi'], ['Katia', '', 'Crovatto'], ['Valerio', '', 'Pazienza'], ['Andrea', 'De', 'Gottardi'], ['Francesco', '', 'Negro']]",Journal of Virological Methods,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0166093405003800', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093405003800']"
10.1053/jhep.1996.v23.pm0008591865,"Lake-Bakaar, G., Ruffini, L., Kuzmič, P., , Effect of Ribavirin and Amantadine on Early Hepatitis C Virus RNA Rebound and Clearance in Serum During Daily High-Dose Interferon, Digestive Diseases and Sciences, 2003",cited-by,10.1023/A:1021798701772,Effect of Ribavirin and Amantadine on Early Hepatitis C Virus RNA Rebound and Clearance in Serum During Daily High-Dose Interferon,"[['Gerond', '', 'Lake-Bakaar'], ['Lynda', '', 'Ruffini'], ['Petr', '', 'Kuzmi\xc4\x8d']]",Digestive Diseases and Sciences,2003,"[u'http://www.springerlink.com/content/l643055004849788', u'http://www.springerlink.com/index/l643055004849788.pdf']"
10.1053/jhep.1996.v23.pm0008591865,"Bekkering, F., Neumann, A., Brouwer, J., et. al, Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients: a case control study, BMC Gastroenterology, 2001",cited-by,10.1186/1471-230X-1-14,Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients: a case control study,"[['Frank', 'C', 'Bekkering'], ['Avidan', 'U', 'Neumann'], ['Johannes', 'T', 'Brouwer'], ['Rachel', 'S', 'Levi-Drummer'], ['Solko', 'W', 'Schalm']]",BMC Gastroenterology,2001,"[u'http://www.biomedcentral.com/content/pdf/1471-230X-1-14.pdf', u'http://www.springerlink.com/index/g835834964j49423.pdf', u'http://www.springerlink.com/content/g835834964j49423', u'http://www.biomedcentral.com/1471-230X/1/14']"
10.1053/jhep.1996.v23.pm0008591865,"Nakamuta, M., Fukutomi, T., Shimohashi, N., et. al, Kinetics of the hepatitis C virus during interferon therapy as a marker of therapeutic response, Journal of Gastroenterology and Hepatology, 2001",cited-by,10.1046/j.1440-1746.2001.02390.x,Kinetics of the hepatitis C virus during interferon therapy as a marker of therapeutic response,"[['Makoto', '', 'Nakamuta'], ['Takayoshi', '', 'Fukutomi'], ['Naoya', '', 'Shimohashi'], ['Naoko', '', 'Kinukawa'], ['Koutaro', '', 'Uchimura'], ['Seiya', '', 'Tada'], ['Kenta', '', 'Motomura'], ['Munechika', '', 'Enjoji'], ['Masaki', '', 'Kato'], ['Hiroaki', '', 'Iwamoto'], ['Yuichi', '', 'Tanabe'], ['Yasuhisa', '', 'Imari'], ['Shigeru', '', 'Sakamoto'], ['Hironori', '', 'Sakai'], ['Hajime', '', 'Nawata']]",Journal of Gastroenterology and Hepatology,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2001.02390.x']
10.1053/jhep.1996.v23.pm0008591865,"Kasahara, A., , Treatment strategies for chronic hepatitis C virus infection, Journal of Gastroenterology, 2000",cited-by,10.1007/s005350070085,Treatment strategies for chronic hepatitis C virus infection,"[['Akinori', '', 'Kasahara']]",Journal of Gastroenterology,2000,"[u'http://www.springerlink.com/content/whx560rhlqukf2g0', u'http://www.springerlink.com/index/whx560rhlqukf2g0.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s005350070085', u'http://www.springerlink.com/index/pdf/10.1007/s005350070085']"
10.1053/jhep.1996.v23.pm0008591865,"Lodato, F., Tamé, M., Colecchia, A., et. al, Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence, , 2006",cited-by,6775086Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence,Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence,"[['Francesca', '', 'Lodato'], ['Maria', 'Rosa', 'Tam\xc3\xa9'], ['Antonio', '', 'Colecchia'], ['Chiara', '', 'Racchini'], ['Francesco', '', 'Azzaroli'], ['Antonia', '', ""D'Errico""], ['Silvia', '', 'Casanova'], ['Antonio', '', 'Pinna'], ['Enrico', '', 'Roda'], ['Giuseppe', '', 'Mazzella']]",,2006,[u'http://www.wjgnet.com/1007-9327/12/4253.pdf']
10.1053/jhep.1996.v23.pm0008591865,"Lédinghen, V., Trimoulet, P., Winnock, M., et. al, Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00026-0,Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C,"[['Victor', 'de', 'L\xc3\xa9dinghen'], ['Pascale', '', 'Trimoulet'], ['Maria', '', 'Winnock'], ['Juliette', '', 'Foucher'], ['Marc', '', 'Bourli\xc3\xa8re'], ['Herv\xc3\xa9', '', 'Desmorat'], ['Val\xc3\xa9rie', '', 'Canva'], ['Dominique', '', 'Capron'], ['St\xc3\xa9phane', '', 'L\xc3\xa9vy'], ['Fran\xc3\xa7ois', '', 'Mion'], ['Paul-R\xc3\xa9gis', '', 'Mannant'], ['Genevi\xc3\xa8ve', '', 'Ch\xc3\xaane'], ['Herv\xc3\xa9', '', 'Fleury'], ['Patrice', '', 'Couzigou'], ['Pierre-Henri', '', 'Bernard']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802000260', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802000260']"
10.1053/jhep.1996.v23.pm0008591865,"Zeuzem, S., , Favourable and disappointing lessons from viral kinetics, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00167-8,Favourable and disappointing lessons from viral kinetics,"[['Stefan', '', 'Zeuzem']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802001678', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802001678']"
10.1053/jhep.1996.v23.pm0008591865,"Bain, V., , Effect of HCV viral dynamics on treatment design: lessons learned from HIV, American Journal of Gastroenterology, 2001",cited-by,10.1111/j.1572-0241.2001.04234.x,Effect of HCV viral dynamics on treatment design: lessons learned from HIV,"[['Vincent', 'G.', 'Bain']]",American Journal of Gastroenterology,2001,"[u'http://dx.doi.org/10.1111/j.1572-0241.2001.04234.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2001.04234.x']"
10.1053/jhep.1996.v23.pm0008591865,"Rossini, A., Artini, M., Levrero, M., et. al, Hepatitis C Virus (HCV) RNA Determination After Two Weeks of Induction Interferon Treatment Is an Accurate Predictor of Nonresponse: Comparison of Two Treatment Schedules, Digestive Diseases and Sciences, 2001",cited-by,10.1023/A:1012303315214,Hepatitis C Virus (HCV) RNA Determination After Two Weeks of Induction Interferon Treatment Is an Accurate Predictor of Nonresponse: Comparison of Two Treatment Schedules,"[['Angelo', '', 'Rossini'], ['Marco', '', 'Artini'], ['Massimo', '', 'Levrero'], ['Cristiana', '', 'Almerighi'], ['Marco', '', 'Massari'], ['Luciano', '', 'Biasi'], ['Enrico', '', 'Radaeli'], ['Elisabetta', '', 'Cariani']]",Digestive Diseases and Sciences,2001,"[u'http://www.springerlink.com/index/g76460316u226432.pdf', u'http://www.springerlink.com/content/g76460316u226432']"
10.1053/jhep.1996.v23.pm0008591865,"Kagawa, T., Hosoi, K., Takashimizu, S., et. al, Comparison of Two Interferon Alfa Treatment Regimens Characterized by an Early Virological Response in Patients With Chronic Hepatitis C, American Journal of Gastroenterology, 1998",cited-by,10.1111/j.1572-0241.1998.00192.x,Comparison of Two Interferon Alfa Treatment Regimens Characterized by an Early Virological Response in Patients With Chronic Hepatitis C,"[['Tatehiro', '', 'Kagawa'], ['Katsumi', '', 'Hosoi'], ['Shinji', '', 'Takashimizu'], ['Kazuya', '', 'Kawazoe'], ['Kaori', '', 'Mochizuki'], ['Mitsuru', '', 'Wasada'], ['Naruhiko', '', 'Nagata'], ['Junzo', '', 'Uchiyama'], ['Atsushi', '', 'Nakano'], ['Yasuhiro', '', 'Nishizaki'], ['Norihito', '', 'Watanabe'], ['Shohei', '', 'Matsuzaki']]",American Journal of Gastroenterology,1998,"[u'http://dx.doi.org/10.1111/j.1572-0241.1998.00192.x', u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1572-0241.1998.00192.x']"
10.1053/jhep.1996.v23.pm0008591865,"Zheng, Y., Min, L., Ji, Y., et. al, Global stability of endemic equilibrium point of basic virus infection model with application to HBV infection, Journal of Systems Science & Complexity, 2010",cited-by,10.1007/s11424-010-8467-0,Global stability of endemic equilibrium point of basic virus infection model with application to HBV infection,"[['Yu', '', 'Zheng'], ['Lequan', '', 'Min'], ['Yu', '', 'Ji'], ['Yongmei', '', 'Su'], ['Yang', '', 'Kuang']]",Journal of Systems Science & Complexity,2010,"[u'http://www.springerlink.com/index/h12l498886678480.pdf', u'http://www.springerlink.com/content/h12l498886678480']"
10.1053/jhep.1996.v23.pm0008591865,"Tural, C., Solà, R., Rubio, R., et. al, Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL1 multicentre pilot study, Journal of Viral Hepatitis, 2007",cited-by,10.1111/j.1365-2893.2007.00860.x,Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL1 multicentre pilot study,"[['C.', '', 'Tural'], ['R.', '', 'Sol\xc3\xa0'], ['R.', '', 'Rubio'], ['M.', '', 'Sant\xc3\xadn'], ['R.', '', 'Planas'], ['C.', '', 'Quereda'], ['J.', '', 'Berenguer'], ['M.', '', 'Montes-Ram\xc3\xadrez'], ['B.', '', 'Clotet']]",Journal of Viral Hepatitis,2007,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2007.00860.x']
10.1053/jhep.1996.v23.pm0008591865,"Zeuzem, S., Herrmann, E., , First-phase parameters in hepatitis C viral kinetics, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00375.x,First-phase parameters in hepatitis C viral kinetics,"[['Stefan', '', 'Zeuzem'], ['Eva', '', 'Herrmann']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00375.x']
10.1053/jhep.1996.v23.pm0008591865,"Enomoto, M., Nishiguchi, S., Shiomi, S., et. al, Changes in serum levels of hepatitis C virus genotype 1b monitored by real-time quantitative polymerase chain reaction as a predictor of long term response to interferon-α treatment, American Journal of Gastroenterology, 2002",cited-by,10.1111/j.1572-0241.2002.05480.x,Changes in serum levels of hepatitis C virus genotype 1b monitored by real-time quantitative polymerase chain reaction as a predictor of long term response to interferon-α treatment,"[['Masaru', '', 'Enomoto'], ['Shuhei', '', 'Nishiguchi'], ['Susumu', '', 'Shiomi'], ['Motoharu', '', 'Tanaka'], ['Tadashi', '', 'Yokogawa'], ['Katsuhiko', '', 'Fukuda'], ['Tadashi', '', 'Ueda'], ['Akihiro', '', 'Tamori'], ['Daiki', '', 'Habu'], ['Tadashi', '', 'Takeda'], ['Yoshihisa', '', 'Yano'], ['Shuzo', '', 'Otani']]",American Journal of Gastroenterology,2002,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2002.05480.x', u'http://dx.doi.org/10.1111/j.1572-0241.2002.05480.x']"
10.1053/jhep.1996.v23.pm0008591865,"Gonzalez, H., Ho, S., Gross, J., et. al, Efficacy of Daily Induction Dosing vs Standard Thrice Weekly Dosing of Interferon-α2B for Initial Treatment of Chronic Hepatitis C, Digestive Diseases and Sciences, 2002",cited-by,10.1023/A:1014792017251,Efficacy of Daily Induction Dosing vs Standard Thrice Weekly Dosing of Interferon-α2B for Initial Treatment of Chronic Hepatitis C,"[['Hernando', 'J.', 'Gonzalez'], ['Samuel', 'B.', 'Ho'], ['John', 'B.', 'Gross'], ['Craig', '', 'Peine'], ['Daniel', '', 'McKee'], ['Theresa', '', 'Smith']]",Digestive Diseases and Sciences,2002,"[u'http://www.springerlink.com/index/1qcgvefwjpnuh7bt.pdf', u'http://www.springerlink.com/content/1qcgvefwjpnuh7bt']"
10.1053/jhep.1996.v23.pm0008591865,"Nakamuta, M., Shimohashi, N., Tada, S., et. al, Serum levels of HCV RNA and core protein before and after incubation at 37°C for 24 h, Hepatology Research, 2001",cited-by,10.1016/S1386-6346(00)00115-7,Serum levels of HCV RNA and core protein before and after incubation at 37°C for 24 h,"[['Makoto', '', 'Nakamuta'], ['Naoya', '', 'Shimohashi'], ['Seiya', '', 'Tada'], ['Naoko', '', 'Kinukawa'], ['Munechika', '', 'Enjoji'], ['Koutaro', '', 'Uchimura'], ['Kenta', '', 'Motomura'], ['Rie', '', 'Sugimoto'], ['Masaki', '', 'Kato'], ['Hiroaki', '', 'Iwamoto'], ['Masami', '', 'Kuniyoshi'], ['Hironori', '', 'Sakai'], ['Hajime', '', 'Nawata']]",Hepatology Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1386634600001157', u'http://linkinghub.elsevier.com/retrieve/pii/S1386634600001157']"
10.1053/jhep.1996.v23.pm0008591865,"Steffan, A., Marianneau, P., Caussin-Schwemling, C., et. al, Ultrastructural observations in hepatitis Cvirus-infected lymphoid cells, Microbes and Infection, 2001",cited-by,10.1016/S1286-4579(01)01369-7,Ultrastructural observations in hepatitis Cvirus-infected lymphoid cells,"[['Anne-Marie', '', 'Steffan'], ['Philippe', '', 'Marianneau'], ['Catherine', '', 'Caussin-Schwemling'], ['Cathy', '', 'Royer'], ['Carine', '', 'Schmitt'], ['Daniel', '', 'Jaeck'], ['Philippe', '', 'Wolf'], ['Jean-Louis', '', 'Gendrault'], ['Fran\xc3\xa7oise', '', 'Stoll-Keller']]",Microbes and Infection,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1286457901013697', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457901013697']"
10.1053/jhep.1996.v23.pm0008591865,"Cabrerizo, M., Bartolomé, J., Sequera, P., et. al, GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells in hemodialysis patients, Kidney International, 1999",cited-by,10.1046/j.1523-1755.1999.00628.x,GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells in hemodialysis patients,"[['Mar\xc3\xada', '', 'Cabrerizo'], ['Javier', '', 'Bartolom\xc3\xa9'], ['Patricia', 'De', 'Sequera'], ['Carlos', '', 'Caramelo'], ['M.', 'Luisa', 'Manzano'], ['Vicente', '', 'Carre\xc3\xb1o']]",Kidney International,1999,"[u'http://www.nature.com/doifinder/10.1046/j.1523-1755.1999.00628.x', u'http://dx.doi.org/10.1046/j.1523-1755.1999.00628.x']"
10.1053/jhep.1996.v23.pm0008591865,"Rocca, P., Chevallier, M., TrÉpo, C., et. al, Auto-immunisation induite par l’interféron alpha dans un contexte d’hépatite virale C chronique, Gastroenterologie Clinique Et Biologique, 2004",cited-by,10.1016/S0399-8320(04)95201-3,Auto-immunisation induite par l’interféron alpha dans un contexte d’hépatite virale C chronique,"[['Pierre', '', 'Rocca'], ['Mich\xc3\xa8le', '', 'Chevallier'], ['Christian', '', 'Tr\xc3\x89po'], ['Fabien', '', 'Zoulim']]",Gastroenterologie Clinique Et Biologique,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0399832004952013', u'http://linkinghub.elsevier.com/retrieve/pii/S0399832004952013']"
10.1053/jhep.1996.v23.pm0008591865,"Pawlotsky, J., , 2 Hepatitis C: Viral markers and quasispecies, Biomedical Research Reports, 2000",cited-by,10.1016/S1874-5326(00)80006-X,2 Hepatitis C: Viral markers and quasispecies,"[['Jean-Michel', '', 'Pawlotsky']]",Biomedical Research Reports,2000,"[u'http://www.sciencedirect.com/science/article/pii/S187453260080006X', u'http://linkinghub.elsevier.com/retrieve/pii/S187453260080006X']"
10.1053/jhep.1996.v23.pm0008591865,"Medeiros-Filho, J., Renato, J., Pinho, R., , Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy, , 0",cited-by,12392872Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy,Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy,"[['Jos\xc3\xa9', 'Eymard', 'Medeiros-Filho'], ['Jo\xc3\xa3o', '', 'Renato'], ['Rebello', '', 'Pinho']]",,0,[u'http://www.wjgnet.com/1007-9327/12/7271.pdf']
10.1053/jhep.1996.v23.pm0008591865,"Senturk, H., Ersoz, G., Ozaras, R., et. al, Interferon-α2b Induction Treatment with or Without Ribavirin in Chronic Hepatitis C: A Multicenter, Randomized, Controlled Trial, Digestive Diseases and Sciences, 2003",cited-by,10.1023/A:1023725014751,"Interferon-α2b Induction Treatment with or Without Ribavirin in Chronic Hepatitis C: A Multicenter, Randomized, Controlled Trial","[['Hakan', '', 'Senturk'], ['Galip', '', 'Ersoz'], ['Resat', '', 'Ozaras'], ['Sabahattin', '', 'Kaymakoglu'], ['Hakan', '', 'Bozkaya'], ['Meral', '', 'Akdogan'], ['Ali', '', 'Mert'], ['Mithat', '', 'Bozdayi'], ['Fehmi', '', 'Tabak'], ['Necati', '', 'Yenice'], ['Gulsen', '', 'Ozbay']]",Digestive Diseases and Sciences,2003,"[u'http://www.springerlink.com/index/q07g04h405411t52.pdf', u'http://www.springerlink.com/content/q07g04h405411t52']"
10.1053/jhep.1996.v23.pm0008591865,"Cacoub, P., Benhamou, Y., , Place des interférons dans le traitement des infections par les virusde l'hépatite B et de l'hépatite C, Revue De Medecine Interne, 2002",cited-by,10.1016/S0248-8663(02)00660-4,Place des interférons dans le traitement des infections par les virusde l'hépatite B et de l'hépatite C,"[['P.', '', 'Cacoub'], ['Y.', '', 'Benhamou']]",Revue De Medecine Interne,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0248866302006604', u'http://linkinghub.elsevier.com/retrieve/pii/S0248866302006604']"
10.1053/jhep.1996.v23.pm0008591865,"Iino, S., , Problems in the Treatment of Hepatitis C with Interferon, Intervirology, 1999",cited-by,10.1159/000024976,Problems in the Treatment of Hepatitis C with Interferon,"[['Shiro', '', 'Iino']]",Intervirology,1999,"[u'http://www.online.karger.com/doi/10.1159/000024976', u'http://www.karger.com/doi/10.1159/000024976']"
10.1053/jhep.1996.v23.pm0008591865,"Zhou, X., Cui, J., , Delay induced stability switches in a viral dynamical model, Nonlinear Dynamics, 2011",cited-by,10.1007/s11071-010-9837-9,Delay induced stability switches in a viral dynamical model,"[['Xueyong', '', 'Zhou'], ['Jingan', '', 'Cui']]",Nonlinear Dynamics,2011,"[u'http://www.springerlink.com/index/8k27140835m3358x.pdf', u'http://www.springerlink.com/content/8k27140835m3358x']"
10.1053/jhep.1996.v23.pm0008591865,"Su, Y., Min, L., , Stability analysis and simulation of an anti-HBV therapy mathematical model with time-delay immune response, , 2011",cited-by,10.1109/ISB.2011.6033163,Stability analysis and simulation of an anti-HBV therapy mathematical model with time-delay immune response,"[['Yongmei', '', 'Su'], ['Lequan', '', 'Min']]",,2011,"[u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=06033163', u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=6033163']"
10.1053/jhep.1996.v23.pm0008591865,"Sgier, C., Müllhaupt, B., Gerlach, T., et. al, Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C: M30 and anti-HCV therapy, Journal of Viral Hepatitis, 2010",cited-by,10.1111/j.1365-2893.2009.01251.x,Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C: M30 and anti-HCV therapy,"[['C.', '', 'Sgier'], ['B.', '', 'M\xc3\xbcllhaupt'], ['T.', '', 'Gerlach'], ['D.', '', 'Moradpour'], ['F.', '', 'Negro'], ['M.', 'H.', 'Heim'], ['R.', '', 'Malinverni'], ['A.', '', 'Cerny'], ['J.-F.', '', 'Dufour']]",Journal of Viral Hepatitis,2010,[u'http://doi.wiley.com/10.1111/j.1365-2893.2009.01251.x']
10.1053/jhep.1996.v23.pm0008591865,"Min, L., Ji, Y., Su, Y., et. al, Global Stability of Endemic Equilibrium Point of Basic Virus Infection Model with Application to HBV Infection, , 2009",cited-by,5139115Global Stability of Endemic Equilibrium Point of Basic Virus Infection Model with Application to HBV Infection,Global Stability of Endemic Equilibrium Point of Basic Virus Infection Model with Application to HBV Infection,"[['Lequan', '', 'Min'], ['Yu', '', 'Ji'], ['Yongmei', '', 'Su'], ['Yang', '', 'Kuang']]",,2009,[u'http://math.la.asu.edu/%7Ekuang/paper/min09.pdf']
10.1053/jhep.1996.v23.pm0008591865,"Min, L., Zheng, Y., SUI, Y., , Study of dynamics of dimensionless basic virus infection model and prediction for long term therapy efficacy, , 2009",cited-by,10.1109/FBIE.2009.5405802,Study of dynamics of dimensionless basic virus infection model and prediction for long term therapy efficacy,"[['Lequan', '', 'Min'], ['Yu', '', 'Zheng'], ['Yongmei', '', 'SUI']]",,2009,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=5405802', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=05405802']"
10.1053/jhep.1996.v23.pm0008591865,"Sypsa, V., Hatzakis, A., , Modelling of viral dynamics in hepatitis B and hepatitis C clinical trials, Statistics in Medicine, 2008",cited-by,10.1002/sim.3457,Modelling of viral dynamics in hepatitis B and hepatitis C clinical trials,"[['Vana', '', 'Sypsa'], ['Angelos', '', 'Hatzakis']]",Statistics in Medicine,2008,[u'http://doi.wiley.com/10.1002/sim.3457']
10.1053/jhep.1996.v23.pm0008591865,"Hu, K., Vierling, J., Redeker, A., , Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection: Factors modulating HCV response to IFN treatment, Journal of Viral Hepatitis, 2008",cited-by,10.1111/j.1365-2893.2001.00253.x,"Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection: Factors modulating HCV response to IFN treatment","[['Ke-Qin', '', 'Hu'], ['John', 'M.', 'Vierling'], ['Allan', 'G.', 'Redeker']]",Journal of Viral Hepatitis,2008,[u'http://doi.wiley.com/10.1111/j.1365-2893.2001.00253.x']
10.1053/jhep.1996.v23.pm0008591865,"Carulli, N., Emilia, R., , The faster the better?, Internal and Emergency Medicine, 2006",cited-by,10.1007/BF02936531,The faster the better?,"[['Nicola', '', 'Carulli'], ['Reggio', '', 'Emilia']]",Internal and Emergency Medicine,2006,"[u'http://www.springerlink.com/index/4xg67r30r7663358.pdf', u'http://www.springerlink.com/content/4xg67r30r7663358', u'http://www.springerlink.com/index/10.1007/BF02936531', u'http://www.springerlink.com/index/pdf/10.1007/BF02936531']"
10.1053/jhep.1996.v23.pm0008591865,"HERRMANN, E., SARRAZIN, C., , Hepatitis C viral kinetics, Journal of Gastroenterology and Hepatology, 2004",cited-by,10.1111/j.1440-1746.2004.03664.x,Hepatitis C viral kinetics,"[['EVA', '', 'HERRMANN'], ['CHRISTOPH', '', 'SARRAZIN']]",Journal of Gastroenterology and Hepatology,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1440-1746.2004.03664.x']
10.1053/jhep.1996.v23.pm0008591865,"Herrmann, E., Zeuzem, S., , Update on viral kinetics and hcv antiviral therapy, Current Hepatitis Reports, 2004",cited-by,10.1007/s11901-004-0002-0,Update on viral kinetics and hcv antiviral therapy,"[['Eva', '', 'Herrmann'], ['Stefan', '', 'Zeuzem']]",Current Hepatitis Reports,2004,"[u'http://www.springerlink.com/index/f64565356th46464.pdf', u'http://www.springerlink.com/content/f64565356th46464', u'http://www.springerlink.com/index/10.1007/s11901-004-0002-0', u'http://www.springerlink.com/index/pdf/10.1007/s11901-004-0002-0']"
10.1053/jhep.1996.v23.pm0008591865,"Strader, D., , Hepatitis C virus among african-american persons, Current Hepatitis Reports, 2004",cited-by,10.1007/s11901-004-0022-9,Hepatitis C virus among african-american persons,"[['Doris', 'B.', 'Strader']]",Current Hepatitis Reports,2004,"[u'http://www.springerlink.com/content/60g615wq1g198470', u'http://www.springerlink.com/index/60g615wq1g198470.pdf', u'http://www.springerlink.com/index/10.1007/s11901-004-0022-9', u'http://www.springerlink.com/index/pdf/10.1007/s11901-004-0022-9']"
10.1053/jhep.1996.v23.pm0008591865,"Sainokami, S., Abe, K., Suzuki, K., et. al, Pretreatment hepatitis C virus dynamics for predicting virological response to interferon-α2b monotherapy in patients with chronic hepatitis C virus infection, Hepatology Research, 2003",cited-by,10.1016/S1386-6346(03)00240-7,Pretreatment hepatitis C virus dynamics for predicting virological response to interferon-α2b monotherapy in patients with chronic hepatitis C virus infection,"[['Shigehiko', '', 'Sainokami'], ['Kouichi', '', 'Abe'], ['Kazuyuki', '', 'Suzuki'], ['Kazuyoshi', '', 'Ishikawa']]",Hepatology Research,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1386634603002407', u'http://linkinghub.elsevier.com/retrieve/pii/S1386634603002407']"
10.1053/jhep.1996.v23.pm0008591865,"Izumi, N., Kumada, H., Hashimoto, N., et. al, Rapid Decrease of Plasma HCV RNA in Early Phase of Twice Daily Administration of 3 MU Doses Interferon-β in Patients with Genotype 1b Hepatitis C Infection, Digestive Diseases and Sciences, 2001",cited-by,10.1023/A:1005686829416,Rapid Decrease of Plasma HCV RNA in Early Phase of Twice Daily Administration of 3 MU Doses Interferon-β in Patients with Genotype 1b Hepatitis C Infection,"[['Namiki', '', 'Izumi'], ['Hiromitsu', '', 'Kumada'], ['Naoaki', '', 'Hashimoto'], ['Hideharu', '', 'Harada'], ['Michio', '', 'Imawari'], ['Mikio', '', 'Zeniya'], ['Gotaro', '', 'Toda']]",Digestive Diseases and Sciences,2001,"[u'http://www.springerlink.com/content/t30666l517u66530', u'http://www.springerlink.com/index/t30666l517u66530.pdf']"
10.1053/jhep.1996.v23.pm0008591865,"Halfon, P., Cacoub, P., , Quantification virale du virus de l'hépatite C : présent et avenir, Revue De Medecine Interne, 2000",cited-by,10.1016/S0248-8663(00)88247-8,Quantification virale du virus de l'hépatite C : présent et avenir,"[['P.', '', 'Halfon'], ['P.', '', 'Cacoub']]",Revue De Medecine Interne,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0248866300882478', u'http://linkinghub.elsevier.com/retrieve/pii/S0248866300882478']"
10.1053/jhep.1996.v23.pm0008591865,"Perry, C., Jarvis, B., , A Review of its Use in the Management of Chronic Hepatitis C, , 0",cited-by,10553240A Review of its Use in the Management of Chronic Hepatitis C,A Review of its Use in the Management of Chronic Hepatitis C,"[['Caroline', 'M.', 'Perry'], ['Blair', '', 'Jarvis']]",,0,"[u'https://www250.safesecureweb.com/hcvadvocate/hepatitis/About_Hepatitis_pdf/1.1_Hepatits_C/Pegasys.pdf', u'http://www.hcvadvocate.org/hepatitis/About_Hepatitis_pdf/1.1_Hepatits_C/Pegasys.pdf']"
10.1053/jhep.1996.v23.pm0008591865,"Medizin, I., , Mathematische Modellierung des frühen Therapieansprechens bei Patienten mit chronischer Hepatitis C, , 0",cited-by,10822653Mathematische Modellierung des frühen Therapieansprechens bei Patienten mit chronischer Hepatitis C,Mathematische Modellierung des frühen Therapieansprechens bei Patienten mit chronischer Hepatitis C,"[['Innere', '', 'Medizin']]",,0,[u'http://www.uni-saarland.de/fileadmin/user_upload/extranet_uds/campus/forschung/forschungsmagazin/2005/1/zeuzem.pdf']
10.1002~hep.510260130,"Zeldis JB, Jensen P. Hepatitis C virus pathogenicity: the corner pieces 1996;23:366-371. of the jigsaw puzzle are found. Gastroenterology 1994;106:1118-1120.",references,NOT found in MAS
10.1002~hep.510260130,"Gretch DR, Bacchi CE, Corey L, Dela Rosa C, Lesniewski RR, Kowdley 30. Viladomiu L, Genesca J, Esteban JI, Allende H, Gonzalez A, LopezK, Gown A, et al. Persistent hepatitis C virus infection after liver trans- Talavera JC, Esteban R, et al. Interferon alpha in acute post-transfusion plantation: clinical and virological features. HEPATOLOGY 1995;22:1-9. hepatitis C: a randomized, controlled trial. HEPATOLOGY 1992;15:767-",references,NOT found in MAS
10.1002~hep.510260130,"Saez-Royuela F, Porres J, Moreno A, Castillo I, Martinez G, Galiana F, 769. Carreno V. High doses of recombinant a-interferon or gamma-inter- 31. Lampertico P, Rumi M, Romeo R, Craxi A, Soffredini R, Biassoni D, feron for chronic hepatitis C: a randomized, controlled trial. HEPATOL- Colombo M. A multicenter randomized controlled trial of recombinant OGY 1991;13:327-331. interferon alpha 2b in patients with acute transfusion associated hepatitis C. HEPATOLOGY 1994;19:19-22.",references,NOT found in MAS
10.1002~hep.510260130,"Marcellin P, Pouteau M, Martinot-Peignoux M, Degos F, Duchatelle V, AID Hepa 0031 / 5p22$$$601 06-11-97 14:14:55 hepa WBS: Hepatology",references,NOT found in MAS
